Alzheimer’s Disease, Dementia & Aging

Soraya L Valles graduated in Biological Science at the University of Valencia in 1985 and in 1996 she finished her PhD in the IIC Institute looking for astrogliogenesis during brain development. In 1997 she spent three years at Hallamshire Hospital, Sheffield, UK. She was working in inflammation and regulation of IL-1 and IL-1 receptor. In 2000 she returned to Spain at Department of Physiology, Faculty of Medicine in University of Valencia until now. She is working in toxicity in developmental and neurodegenerative disease (such as Alzheimer’s disease) looking for oxidative stress and inflammation mechanisms.

Neurodegenerative disease, Inflammation mechanisms, Alzheimer’s disease

Experienced manager with a demonstrated history of working in care homes for the elderly who suffer Alzheimer’s disease and dementia. A specialist in the field of Alzheimer care with relentless curiosity, intellectual and creative personality. Strong professional with a Master's degree in Psychology from SWPS University of Social Sciences and Humanities, BA (Hons) degree in Tourism Management from Bournemouth University and course in Psychology of Addiction from Oxford University. Member of British Psychological Society BPS.

Alzheimer care

Mourad Tayebi is Associate Professor in Biomedical Sciences at the School of Medicine, Western Sydney University, AUSTRALIA. Dr. Tayebi is an international expert in the field of PROTEIN MISFOLDING DISEASES, with specific focus on investigating the molecular mechanisms underlying pathogenic protein misfolding and characterizing the misfoldome associated with these disorders. Dr. Tayebi’s team is very active in the development of early blood diagnostic test screen for Alzheimer and effective therapies for neurodegenerative diseases.

Protein misfolding diseases, Blood Diagnostic Test, Neurodegenerative Diseases

TY Chang shares the same laboratory with his wife and long-term collaborator Dr. Catherine Chang at Geisel School of Medicine at Dartmouth. They have been working on cholesterol metabolism research for more than four decades. The Changs and their colleagues did ground breaking work by identifying the gene that encodes the cholesterol storage enzyme acyl-CoA:cholesterol acyltransferase 1 (ACAT1/SOAT1). For this work, Dr. T.Y. Chang received a MERIT award from NIH, USA. More recently, the Chang lab at Dartmouth demonstrated ACAT1 as a potential target for treating several human diseases, including Alzheimer’s disease and Niemann-Pick type C disease.

Niemann-Pick type C disease, Alzheimer’s disease, cholesterol homeostasis.

Catherine Chang is the co-Principal Investigator of the Chang laboratory at Geisel School of Medicine at Dartmouth, with her husband and long-term collaborator Dr. T.Y. Chang as the PI. They have been working on cholesterol metabolism research for more than four decades. The Changs and their colleagues did ground breaking work by identifying the gene that encodes the cholesterol storage enzyme acyl-CoA:cholesterol acyltransferase 1 (ACAT1/SOAT1). Subsequently, they performed extensive functional analysis of the enzyme. More recently, they demonstrated ACAT1 as a potential target for treating several human diseases, including Alzheimer’s disease and Niemann-Pick type C disease.

Alzheimer’s disease and Niemann-Pick type C disease, cholesterol storage enzyme.

Yingxu Wang is professor of cognitive informatics, brain science and denotational mathematics. He is President of International Institute of Cognitive Informatics and Cognitive Computing (ICIC). He is Fellows of BCS, ICIC, WIF, and Senior Members of IEEE and ACM. He has held visiting professor positions at Oxford University (’95), Stanford University (‘08|’16), UC Berkeley (‘08), and MIT (‘12). He is the initiator of fields of cognitive informatics, denotational mathematics, abstract intelligence (aI), neural circuit theory, formal brain models, cognitive robots and cognitive machine learning. He is a top 2.5% scholar worldwide and top 10 at UCalgary according to Research Gate’s statistics.

Neuroinformatics, neurology, neural signaling systems, spike frequency modulation, SFM, cognitive informatics, mathematical models, neural networks, cognitive system, cognitive robots, brain-machine interface

Yingxu Wang is professor of cognitive informatics, brain science and denotational mathematics. He is President of International Institute of Cognitive Informatics and Cognitive Computing (ICIC). He is Fellows of BCS, ICIC, WIF, and Senior Members of IEEE and ACM. He has held visiting professor positions at Oxford University (’95), Stanford University (‘08|’16), UC Berkeley (‘08), and MIT (‘12). He is the initiator of fields of cognitive informatics, denotational mathematics, abstract intelligence (aI), neural circuit theory, formal brain models, cognitive robots and cognitive machine learning. He is a top 2.5% scholar worldwide and top 10 at UCalgary according to Research Gate’s statistics

Neuroinformatics, neurology, neural signaling systems, spike frequency modulation, SFM, cognitive informatics, mathematical models, neural networks, cognitive system, cognitive robots, brain-machine interface

Founding Member (2007) and Prime Vice-President of the Romanian Society for Neurorehabilitation (RoSNeRa) - affiliated to WFNR. Founding Member and Prime Vice-President of the Romanian Spinal Cord Society (RoSCoS) - affiliated to ISCoS) and ESCIF. Member of the International Spinal Cord Society (ISCoS, since 2000), World Federation for Neurorehabiliation (WFNR, since 2008), Euroacademia Multidisciplinaria Neurotraumatologica (EMN, since European Federation of NeuroRehabilitation (since 2014), International Parkinson and Movement Disorder Society (since 2016), and in many Romanian Scientific Societies. Coordinator of the Romanian team in 5 international projects, participant in 4 national projects. He participated to the educational project "eleanSCI.org", launched by ISCoS in 2012.

Actively implied in national educational prophylactic interventions, aimed to prevent severe central nervous lesions (TBI and SCI ─ http://www.worldsciday.org/romania_avs.html “Prevention of SCI AV for General Public 00:15 secs”). Co-author of 2 patent certificates (appointed by the Romanian State Office for Inventions and Marks, OSIM), 9 books, and over 60 published papers. Fluently in English and French.

Yingxu Wang is professor of cognitive informatics, brain science and denotational mathematics. He is President of International Institute of Cognitive Informatics and Cognitive Computing (ICIC). He is Fellows of BCS, ICIC, WIF, and Senior Members of IEEE and ACM. He has held visiting professor positions at Oxford University (’95), Stanford University (‘08|’16), UC Berkeley (‘08), and MIT (‘12). He is the initiator of fields of cognitive informatics, denotational mathematics, abstract intelligence (aI), neural circuit theory, formal brain models, cognitive robots and cognitive machine learning. He is a top 2.5% scholar worldwide and top 10 at UCalgary according to Research Gate’s statistics

Neuroinformatics, neurology, neural signaling systems, spike frequency modulation, SFM, cognitive informatics, mathematical models, neural networks, cognitive system, cognitive robots, brain-machine interface

Biography DR. MANUEL VELASCO STUDIES: HIGH SCHOOL AND COLLEGE: Liceo Francisco de Miranda, Los Teques, Venezuela, 1962 UNIVERSITY: Universidad Central de Venezuela, Caracas, Venezuela, 1968 POSTGRADE STUDIES: Intern IN Medicina Interna (CLINICAL PHARMACOLOGY), Hahnemann Medical College and Hospital, Philadelphia, Pa., USA. Fellowship IN Medicina Interna (CARDIOVASCULAR CLINICAL PHARMACOLOGY), Emory University School of Medicine, Atlanta, Ga., USA Julio 1972 – Diciembre 1974. DOCTORATE IN MEDICAL SCIENCES: Universidad Nacional del Zulia, Maracaibo, Estado Zulia, Venezuela, 1979. POSITIONS: Jefe de Catedra de Farmacología, Escuela de Medicina Vargas, Caracas, Venezuela, 2001-2003 Jefe de Departamento de Ciencias Fisiologicas, Escuela de Medicina Vargas, Caracas, Venezuela, 2001-2003 Coordinador General, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela, 2002-2004 Director, Unidad de Farmacología Clínica, Hospital Vargas, Caracas, Venezuela, desde 1976 Director, Unidad de Hipertensión, Hospital Vargas, Caracas, Venezuela, desde 1985. Director, Unidad de Farmacología Clinica Cardiovascular y Respiratoria, Escuela de Medicina Vargas, Caracas, Venezuela, desde 2002

RESEARCH INTERESTS: Methodology in Radioisotopes, Advance course of Biostathistics, Medical course in Radioisotopes, Advance course of clinical pharmacology.

Kenneth Blum is widely designated as Father of Psychiatric Genetics because of the of the DRD2 gene and its correlation with various psychiatric disorders including the “Reward Defi ciency Syndrome” (RDS) which term he has coined. He is also known as the “Father of Neuro- Nutrient Therapy “ for his discovery of successful nutrient therapy for RDS. He holds numerous domestic and foreign patents and is co-founder and Chairman & CSO of LifeGen Inc. He is a former Full Professor in the Department of Pharmacology, University of Texas Health Science Center, San Antonio, Texas; Volunteer Professor in the Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida and Adjunct Full Professor of Psychiatry at the University of Vermont College of Medicine, Burlington, Vermont. He currently serves as Neuroscience advisor for Dominion Diagnostics., LLC North Kingstown, Rhode island, Malibu Beach Recovery Center, Malibu Beach California, and is the Scientifi c Director of PATH Foundation NY, New York. He is an honorary Faculty of IIOAB, India. He has been recently appointed Chief Scientifi c Offi cer(CSO) of G&G Holistic Addiction Treatment Centers in North Miami Beach Florida. To his credit he has over 400 publications in peer reviewed journals, 14 books and has received many awards including a Lifetime Achievement Award from the National Institute of Holistic Addiction Studies.

neuropsychopharmacology,genetics,genetics of alcoholism, neuropsychiatry,pharmacogenetics and Blum's research has been recognized through numerous awards.

January 2003 – July 2005. Currently forming part of a professional training period at the General Sleep Disorders Unit in service of the Clinical Neurophysiology of the Complejo Hospitalario de Toledo, in which I was in charge of evaluating patients with various sleep disorders particularly; apnoea, narcolepsy, restless legs syndrome, REM nightmares, night-terrors, sleep paralysis, nocturnal epilepsy (55 of these patients suffer from chronic insomnia and are part of my research project), hypersomnia (2 publications) with the evaluation of more than 500 patients a year and 150 night polysomnographies a year.( Technical handling, recording and analysis). The technical handling and analysis of Multimodal evoked potentials (somatosensory, visual electroretinogram and trunk audiometry). While working at the Clinical Neurophysiology Service at the Toledo Hospital Complex I undertook a three-month July 2005- JULY de 2015, 10 YEARS professional experience in the Neurophysiology Clinic in the Private Medical Centre Virgen de la Caridad, in Cartagena, Murcia, Spain which works in conjunction with the Social Security hospitals, (Santa Maria del Rosell Hospital, Naval Hospital in Cartagena, and los Arcos Hospital in Santiago de la Ribera). During the last seven years in this Centre my work related to: 9 EEG. electroencephalography /week 45 EMG. electromyography/ week 1-2 PEAT evoked potential / week 20 PSGN polysomnography /week. Professional experience: Experience in the analysis of- electroencephalography ( young children and adults) and also: -polysomnography (System Medelec Profile y Medelec Synergy- Oxford. Keypoint Medtronic System (EMG). -Electromyography - Practical experience with analysis system PUM and sensory and motor conduction and also in electromyography. Medelec Synergy and Keypoint .-Oxford.

Neurology, Seminars of Neurology, Research Techniques in Neurology, Neurobiology of sleep, Physiology of excitable membranes, Inter-functional relation between the nervous and immune system.

Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration

The major focus of this laboratory has been to study the mechanisms of topographic regulation of neuronal cytoskeletal proteins regulation by phosphorylation and neurodegeneration. In a normal physiological state, cytoskeletal proteins are phosphorylated extensively in the axonal compartment of a mature neuron. Although all the substrates, kinases, phosphatases and their regulators are synthesized in neuronal cell bodies, little or no cytoskeletal protein phosphorylation has been detected in the cell body compartment. Under a variety of neuropathological conditions, however, such as ALS, Alzheimers Disease, or Picks disease, hyperphosphorylation of these molecules has been found in abnormal aggregates within cell bodies, usually correlated with massive neuronal cell death. The mechanisms underlying these profound compartmental shifts in neuronal phosphorylation are not well understood.The normal physiological processes within neurons are controlled by signal transduction mechanisms that regulate the balance between protein kinase and protein phosphatase activities. We have shown that the most abundant and extensively phosphorylated motifs in the c-terminal domains (lys-ser-pro-, or KSP) are primarily phosphorylated by proline directed kinases, cdk5 and MAP kinases. Moreover, we have demonstrated that this phosphorylation is due to activation of the signal transduction cascade. Recently, we have focussed on the other part of this regulation, the protein phosphatases. The other project is to study the expression, regulation and role of neuronal Cdk5 in nerve cell function.Cdk5 is a unique multifunctional kinase. Unlike other cyclin-dependent kinases, it is expressed predominantly in post-mitotic neurons, its activity modulated by association with nervous system-specific propeins. Since its identification and characterization in our laboratory, we have been intensively studying its mechanisms of regulation and its role in nerve cell function.

Dr Felix U. Uduma, MB.BCh, FWACS, FICS is a senior Lecturer in Department Of Radiology,in Faculty Of Clinical Sciences, College Of Health Sciences, University Of Uyo, Uyo, Nigeria. He is the Head of Department of Radiology in University of Uyo,Nigeria. He is a former Adjunct Lecturer in Madonna University, Elele, Nigeria and also a former Consultant Radiologist, Polyclinic Bonanjo, Douala, Cameroon. Dr. Uduma is a member of Medical Advisory Board in University of Uyo teaching hospital, Nigeria. He is also an associate Editor of many journals including West African Journal of Radiology. He has published not less than 30 articles.

Medicine, choroid plexus calcifications,epilepsy, cerebral hemiatrophy in childhood

Dr. Mohan received his Bachelor of Science (HONS) degree in Pharmacology from University of Hertfordshire, England, UK in 2002. During this time, Dr. Mohan was awarded a research scholarship to study and perform research in the USA. During his one-year research scholarship, Dr. Mohan worked on understanding genes responsible for antibiotic resistance in ocean samples collected from the South Pole.After graduating with his B.Sc., Dr. Mohan had a short stint in big pharma., with Pfizer Inc., focusing his research efforts on sexual health and urology discovery. After Pfizer, Dr. Mohan returned to the USA after being accepted onto a Ph.D. program in Biomedical Science in the Dept. of Pharmacology & Physiology, College of Medicine at Oklahoma State Univ. After publishing his work on opioid neuropharmacology and graduating with his Ph.D. in 2008 Dr. Mohan accepted a postdoctoral assistant position at the Univ. of Iowa. During his time in Iowa, Dr. Mohan concentrated on gaining valuable experience pertaining clinical pain, focusing on postoperative pain and discovery of novel targets to alleviate acute pain following surgery.Dr. Mohan served as the President for the North Central Florida Chapter of the Society for Neuroscience (SfN) from 2013 – 2014. Dr. Mohan is a member of the Society for Neuroscience, American Heart Association and the International Society for Neuroimmunology. Dr. Mohan has taught and mentored numerous undergraduate and graduate students during his research career. Dr. Mohan is currently a Advisory Board Member for the Sia Brain Awareness Foundation and a peer-reviewer for the J. of Pain Research and on the editorial board of the J. Pharmaceutical Sciences. Dr. Mohan is also a coalition member for Cabell County Substance Abuse Prevention Partnership (CCSAPP) here in Huntington, WV.

Dr. Mohan’s current research focus is on understanding the exposure of neurotoxic substances during development and how they affect neural plasticity and neurovascular of the brain.

Abbas Alnaji had his Board degree of Neurosurgery from University of Baghdad and the consultant from Iraqi ministry of health 2015. In 2016 he became the member of editorial board for the journal of Neurology and Experimental Neural Science, by GAVIN publishers. He is also an Associate editor for Global Journal of Intellectual & Developmental Disabilities (GJIDD).Recently he has befit the editorial board member for SciFed Orthopedics & Rheumatology Research journal and Ocular Biology journal.

He is interested in research work and has eleven papers published in the field of surgical pathology causation.Interested in the biological bases of medic-surgical pathologies in his field.

Giuseppe Scalabrino studied at the School of Medicine of the University of Milan and received his M.D. degree magna cum laude in 1968. He has held a number of academic positions in the Faculty of Medicine of the University of Milan. He was Associate Professor of General Pathology between 1971 and 1985; full Professor of General Pathology from 1986 till 2014. He has been invited speaker in various conferences, mainly dealing with the role of polyamines in oncology and subsequently with the cobalamin (vitamin B12) neurotrophism. Among his numerous honors, he received the International Award "Roentgen" from Italian Accademia dei Lincei in Rome for oncological research in 1983. He is author of more than 100 scientific papers and reviewer of numerous International Journals. Dr. Scalabrino's studies of cobalamin neurotrophism have been mentioned and reviewed in 12 american textbooks of neurology, biochemistry, hematology, and vitaminology

From many years, Dr. Scalabrino is usually reviewer for many international journals in the field of neurobiology, oncology, and molecular biology.

Queen Mokhuane is presently Acting Executive Director: Student Affairs and is also the Professor and Head in the department of Clinical Psychology at Medunsa Campus. She has an extensive experience in academia, students, teaching and student life including management. She has also received training in the auditing of institutions of higher learning. She holds a doctoral degree in Psychology (UNISA) and fellow ship in Public Health obtained from the University of Washington, Seattle, USA and an Internship in HIV/AIDS at the Seattle Community Mental Health. Queen has been extensively involved with international organizations such as the Kellogg’s Foundation and assisted in the development of academic and research projects for the training of health care personnel. She has been also involved in Mental Health Policy Initiative (Department of Health SA) Children’s Rights (Human Rights Division) – Geneva. To this effect, she was a member of Committee on the Rights of the Child 1999-2001. She is a member of various professional organizations and has referred scientific papers. She has produced a booklet for training for the National Prosecuting Agency with regard to the identification of child abuse and the different forms of child abuse including intervention strategies. Currently she is Chairperson of the Professional Board for Psychology and Chairperson Health Committee of the HPCSA.

Psychology,member of various professional organizations and has referred scientific papers.

Dr. Nagaraj Pushparaj is the Director & Chief Consultant at PMN Physiotherapy Speciaality Pranikha Sports Medicine Pain Relief Centre and he is currently working as a consultant Neuro Science & Sports Medicine Rehabilitation Neuro Developmental Therapist at Be Well Hospitals.

Physiotherapy, Neuro Science & Sports Medicine and Neuro Rehabilitation.

born on April 12, 1959 in Pilsum (East Friesland); 1979-1986 Medical studies at the Medical University of Hanover; 1988 Promotion (magna cum laude) with the theme "Investigations of electrophysiological, biochemical and psychometric parameters in hepatic encephalopathy "; 1990-1993 assistant physician at the psychiatric clinic, University of Göttingen; 1997 Specialist physician for psychiatry and neurology, since also lead the working group "Molecular Neurobiology" of the Psychiatric Clinic, University Goettingen. Since 1999 he has been the Clinical Director of the Psychiatric Clinic. 2001 Acquisition of the Additional description Psychotherapie / Facharzt für Psychiatrie und Psychotherapie. 2002 Habilitation, since then: Extraordinariat (C3 professorship) for psychiatry and psychotherapy; Deputy. Clinic Director & Ltd. Oberarzt, Head of the Polyclinic & Institute's Institute, FriedrichAlexander-University Erlangen-Nuremberg; Head of the Research Laboratory for Molecular Neurobiology, clinic with polyclinic for psychiatry and psychotherapy, Friedrich-AlexanderUniversität Erlangen-Nuremberg

Molecular Neurobiology,psychiatry and psychotherapy.

• 2017 to continue Lancet Commissioner for LMIC • 2014 to continue member of Teaching Course Committee, World Federation of Neurology (WFN). • 2014 – 2016 member of Scientific Committee of European Academy of Neurology (EAN). • 2013-2014 Rector of University of Medicine, Tirana • 2010 to continue Faculty in CONy Congresses • 2010-2013 Health National Contact Point, European Commission, CORDIS Fp7 programme • 2003 to continue: reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy, Patients and Reference, British Journal of Pharmaceutical Research, British Journal of Medicine and Medical Research, International Neuropsychiatric Disease Journal, BMJ Case Reports, etc. • February 2003 – 2011 – Trainer of European Academy of Epilepsy. • 2000 to continue: Member of editing board of OA Publishing London, WebMed Central Brain Editor, Confinia Cephalalgica, Parma, Emilia-Romagna, Italy; Contributer in Cochrane MS; Albanian Medical Journal, Albanian Journal of Medical and Health Sciences, University of Medicine, Tirana, • 1998-2007 - President of Albanian Society of Neurology (ASN). • 1997 to continue - Head of the University Service of Neurology (UHC Mother Teresa, Tirana). • 1981 to continue - Lecturer: Faculty of Medicine, Neurology Department. University of Tirana (University of Medicine since January 2013).

Neurology

Dr. Umeton is Research Associate at the Institute of Neuroscience, Newcastle University, investigating the neural computations underlying visual perception and stereopsis. Dr. Umeton received her PhD and postgraduate studies from University of Calabria, Italy, but has gain extensive research experience working for Newcastle University (UK), Calgary University (CA) and Universidad Complutence de Madrid (ES) .

Neural computations underlying visual perception and stereopsis

-

-

-

-

-

-

Dr. George Perry is currently the dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. After graduation in Zoology from University of California, Santa Barbara, he headed to Scripps Institution of Oceanography and also studied at Hopkins Marine Station of Stanford University and the Marine Biological Laboratory of Woods Hole and obtained his PhD in Marine Biology in 1979. Dr. Perry joined the faculty of Case Western Reserve University in 1995, where he currently holds an adjunct appointment. He is a Fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Medicine, Royal Society of Chemistry, Society of Biology and the Linnean Society and past-president of the American Association of Neuropathologists. He has been elected member of the Spanish Royal Academy of Sciences, Mexican Academy of Sciences and Academy of Sciences Lisbon; Iberoamerican Molecular Biology Organization, Dana Alliance for Brain Initiatives and won the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native Americans in Science, Senior Investigator Award from the International College of Geriatric psychoneuropharmacology, Senior Fulbright Fellow and the National Honor Plaque of Panama for exceptional contributions to Neuroscience. Dr. Perry is on Board of the National Organization of Portuguese Americans and serves as Director of Education and Research.

-

-

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

-

-

Vahe Poghosyan received his MSc in Mathematics (1997) from Yerevan State University and PhD in Neurophysiology (2000) from National Academy of Sciences of Armenia. He held positions of Research Scientist in RIKEN Brain Science Institute in Japan (2000-2007), and Senior Scientist (2007-2016) and Director of Research Training Program (2011-2016) at AAI Scientific Cultural Services Ltd. in Cyprus. Currently, he is the Head of MEG Laboratory and Consultant Neuronavigation at King Fahad Medical City in Riyadh, KSA.

Dr. DeFeo is noted as one of the leading experts of the DSM-5 in the State of California. She has conducted over 50 state, national, and international trainings on the topic. Dr. DeFeo was the highlighted presenter at the 18th Annual Inter-national Violence, Abuse, and Trauma Conference (IVAT) in San Diego in September, 2013, the 18th Annual IVAT Conference in Honolulu, Hawaii in March, 2014, and the Illinois American Association for Marriage and Family Therapy Annual Conference in Naperville, Illinois to conduct a full 7 hour workshop to educate Clinical Psychologists, Social Workers, Marriage and Family Therapists, Psychiatrists, and Medical Doctors/Professionals on the DSM-5 and ICD-10 diagnostic systems. Dr. DeFeo’s DSM-5 and ICD-10 training is also an approved accredited workshop with the Association for Advanced Training in the Behavioral Sciences (AATBS) to train social workers, psychologists, psychiatrists, medical physicians, and marriage and family therapists in the United States. Additionally, Dr. DeFeo is working with the Mexican Board of Professionals to institute the DSM-5 into the Mexican Higher Education Institutions, and has presented this topic at the First Annual Psychological Society Conference in Buenos Aires, Argentina in October, 2014 and various locations in Mexico (Tijuana, Ensenada, and Mexicali). Dr. DeFeo presently is a California licensed psychologist, distinguished professor of psychology, and Interim Associate Chair for the Department of Marriage and Family Therapy at the Chicago School of Professional Psychology in Irvine, California where she has been working since 2010. Dr. DeFeo also is a senior reviewer and editor for the Journal of Psychiatry, OMICS, and the Journal of Hispanic Higher Education.

Dr. George Perry is currently the dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. After graduation in Zoology from University of California, Santa Barbara, he headed to Scripps Institution of Oceanography and also studied at Hopkins Marine Station of Stanford University and the Marine Biological Laboratory of Woods Hole and obtained his PhD in Marine Biology in 1979. Dr. Perry joined the faculty of Case Western Reserve University in 1995, where he currently holds an adjunct appointment. He is a Fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Medicine, Royal Society of Chemistry, Society of Biology and the Linnean Society and past-president of the American Association of Neuropathologists. He has been elected member of the Spanish Royal Academy of Sciences, Mexican Academy of Sciences and Academy of Sciences Lisbon; Iberoamerican Molecular Biology Organization, Dana Alliance for Brain Initiatives and won the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native Americans in Science, Senior Investigator Award from the International College of Geriatric psychoneuropharmacology, Senior Fulbright Fellow and the National Honor Plaque of Panama for exceptional contributions to Neuroscience. Dr. Perry is on Board of the National Organization of Portuguese Americans and serves as Director of Education and Research.

Guy H Fontaine has made 15 original contributions at the inception of pacemakers since early 60s. He has serendipitously identified Arrhythmogenic Right Ventricular Dysplasia in the late 70s. He has published more than 900 scientific papers including 201 book chapters. He was the reviewer of 17 journals in Clinical and Basic Science. He served during 5 years as a Member of the Editorial Board of Circulation. He has been invited to give 11 master lectures of 90 minutes each during three weeks in the top universities of China (2014).

Dr. Wang is Director of Neuroapoptosis Drug Discovery Laboratory, Department of Neurosurgery, Brigham and Women’s Hospital/Harvard Medical School. Dr. Wang received her PhD from Hebrew University of Jerusalem. She did her postdoctoral training at University of Michigan and Harvard Medical School. Dr. Wang has published about 70 peer-reviewed articles and has served as the Guest Editor, Handling Editor, and Editorial Board Member for a number of peer-reviewed journals, as well as the scientist reviewer for institutes or foundations including NIH, DOD, BSF, and others, and invited reviewer for 34 peer-reviewed journals.

Currently I am working as Research Scientist in the Department of Neurology at University of Iowa, Iowa, USA. I did my B.Sc. (Chemistry) in 2003, M.Sc. (Organic Chemistry) in 2005 from Aligarh Muslim University and Ph.D. (Toxicology) in 2009 from the department of Toxicology, Hamdard University, Delhi, India. After completion of my Ph.D. program, I have joined the Department of Internal medicine as postdoctoral Research Associate. Here I focused my research on understanding the role of plasma glycoprotein von Willebrand factor (VWF) and VWF-cleaving protease ADAMTS13 in animal model of stroke. After that I joined the department of Neurology as an Associate Scientist. Here my research investigates the molecular mechanisms that regulate inflammation in the central nervous system that are critical to our understanding of a broad spectrum of neurodegenerative diseases, including Parkinson’s disease, stroke, Alzheimer’s disease, multiple sclerosis and traumatic brain injury. I am the member of several international societies and enlisted in the Editorial board of the journal.I have published almost 40 peer reviewed original research publications and almost 50 abstracts in National and International Neuroscience-related meeting and conferences.

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Kurt A Jellinger, born 1931 in Vienna, is Professor of Neurology and Neuropathology at the Medical University of Vienna (Vienna, Austria), was director of the Department of Neurology, Lainz Hospital in Vienna and since 2002, director of the Institute of Clinical Neurobiology (Vienna, Austria). He has been the recipient of numerous international grants and awards, is a member of numerous national and international scientific societies, editor of many international journals of neurology, neuroscience and neuropathology. His publication records exceeds 1,000 in perr-reviewed journals, 170 contributions in scientific book, inclduding several as editor, as well as 1.300 lectures at international meetings. For the last 50 years, his research included many fields of clinical neuropathology, neurochemistry and descriptive neurobiology.

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants, including Health and Medical Research Fund, National Natural Science Foundation of China, General Research Fund, General Research Fund, He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Structural and functional MRI correlates of Post stroke Depression

Dr Krupa Torne is among the few super specialists who have been internationally trained in the field of Paediatric Neurology.At present she is heading the department of Neurosciences at Surya Children’s multispecialty Hospital in Mumbai, India. She has completed her Fellowship in Paediatric Neurology and Epilepsy from Maharashtra University Health Sciences at Lokmanya Tilak Municipal Hospital and Lokmanya Tilak Municipal Medical College, Mumbai. She has had a brief stint at the University College London Hospital, a premier academic institution cum hospital in the UK. She has been trained in Paediatric Neurology at Birmingham Children's Hospital where she successfully completed her International Fellowship in Paediatric Neurology, Epilepsy and Neurorehabilitation. To complement her advanced training in Paediatric Neurology she has completed many prestigious International courses like British Paediatric Epilepsy Training Course, British Paediatric Movement disorder Training Course in UK. She has also been trained for Ketogenic diet for drug resistant childhood epilepsies at the Asian Institute of Ketogenic Diet. Dr Torne has many accolades to her name which complements her meticulous and explicate personality. She was honoured by International Bursary from European Paediatric Neurology Society with an opportunity to attend one of the prestigious courses in Paediatric Neuromuscular disorder and Neonatal Neurology at Budapest in Hungary. She was invited to attend the valuable Movement Disorder International Winter School Course by Movement Disorder International society at Catania in Italy. As a feather in her cap she was invited as a Chief Guest in World Congress of Anatomist held in Gadag Institute of Medical Sciences in Karnataka. She has to her credit valuable publications in reputed peer reviewed International Journals. She has presented many national and international papers in Cambridge, Birmingham, Italy, France and Hungary. She is affiliated to many International and National Paediatric Neurology and Epilepsy associations.

Complex Paediatric Epilepsies, Ketogenic diet and Paediatric Movement Disorder.

Dr. Rajendra D. Badgaiyan, MD, is a psychiatrist and cognitive neuroscientist. He is Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. He received formal training in psychiatry, psychology, cognitive neuroscience, molecular imaging and neuroimaging. He was awarded the prestigious BK Anand National Research Prize in India and Solomon Award of Harvard Medical School. His research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published extensively in peer-reviewed journals.

Neural and Neurochemical mechanisms in Human Cognition and Behaviour

George Perry (born April 12, 1953 in Lompoc, California) is a neuroscientist recognized in the field of Alzheimer's disease research particularly for his work in oxidative stress. Dr. Perry has studied at many universities and holds multiple degrees including a Bachelor of Arts degree in Zoology from the University of California Santa Barbara and a PhD in Marine Biology from the University of California at San Diego. He is distinguished as one of the top Alzheimer’s disease researchers with over 1000 publications, more than 60,000 citations, one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in free radical research. Dr. Perry is a Semmes Foundation Distinguished chair in Neurobiology and is an active participant in many other scientific associations. In addition, Perry is an Editor of numerous scientific journals including Journal of Alzheimer’s Disease which he founded in 1998. Today, Perry continues his love for research while working as Dean of the College of Sciences at The University of Texas at San Antonio.

Alzheimer's disease, Neurobiology, Oxidative stress

Dr. Jesse Michael Weinberger is 1978 - 1983 Assistant Professor of Neurology, Mount Sinai School of Medicine, New York, NY; 1983 - 1991 Associate Professor of Neurology, The Mount Sinai School of Medicine, New York, NY; 1983 - 1990 Adjunct Professor, Hunter College of the City University of New York; 1991 - present Professor of Neurology, The Mount Sinai School of Medicine, New York, NY. He also got certified in Neurology, The American Board of Psychiatry and Neurology, October 1976 Certificate #15840; Neurosonology, American Society of Neuroimaging, 1989; Vascular Neurology, American Board of Psychiatry and Neurology, May 2005 to December 31, 2015.

Vascular Neurology, Neurology

Dr. AlKherayf is an Associate Professor and a Neurosurgeon at University of Ottawa. He is also a neuroscientist at the Ottawa Hospital Research Institute (OHRI) with a cross appointment to the Clinical Epidemiology Program. He is the Director of the Clinical Research Program at the Division of Neurosurgery at the Ottawa Hospital, and the Director of Spine Fellowship Program at University of Ottawa. After graduating from medical school he completed his neurosurgery training at University of Ottawa in 2010. He also completed two fellowships in complex spine surgery and minimally invasive skull base surgery. Additionally, he has training in clinical epidemiology and biostatistics (MSc, Epidemiology and Biostatistics 2011) and has completed the Clinician Investigator Program certified by the Royall College of Physician and Surgeons of Canada (RCPSC). Dr. AlKherayf’s clinical practice is focused on complex spine surgery, minimally invasive cranial surgery and complex cranio-cervical reconstruction. His clinical research interests lie on translational primary brain tumor research, clinical trials, and spinal cord injury. He has authored and co-authored many research papers and abstracts, and spoken at many international conferences. Dr. AlKherayf has special interest in neurosurgery and spine education by directing many training courses. He also has been serving as an editorial board member of many journals.

Neurosurgery

Steven Wagner earned his MS and PhD degrees in biochemistry from the University of Louisville School of Medicine and did post-doctoral training in microbiology and molecular genetics and UC Irvine College of Medicine. He then served as Director of Biochemistry at the Salk institute Biotechnology/Industrial Associates, Inc., followed by a position as Chief Scientific Officer at Neurogenetics, Inc./TorreyPines Therapeutics, Inc. In 2009 he joined UC San Diego's Department of Neurosciences, where he currently is an associate professor and principal investigator. Dr. Wagner's research focuses on the discovery, design and preclinical development of therapeutic small molecules known as gamma-secretase modulators (GSaMs). These drug-like small molecules are aimed at preventing and/or delaying the buildup of specific neuropathological lesions known as neuritic plaques that are invariably abundant in the brains of both patients with Down syndrome and Alzheimer's disease.

Neurosciences

Dr. Antonio De Thommasi is Chairman and Head of the Neurosurgical and Neurotraumatological Department at Bari General Hospital and University of Bari – 11, Piazza Giulio Cesare, 70124, Bari, Italy. He also worked as Deputy Head and Associate Professor of Neurosurgery and Neurotraumatology at Bari General Hospital and University of Bari. he has done Degree in Medicine from University of Bari, Italy (from 1966 -to 1972).

Neurosurgery and Neurotraumatology

Dr. Martin Scholz is worked as a MD since 2009, due to the gradual painstaking work, with modern upgrades, Neurosurgical Center "Veda" - is a unique place, where provided the best diagnosis and therapy in Germany in the field of the human nervous system pathologies. Drew attention to the practice of doctors' offices paid to various refresher courses, specialized international seminars with the aim of continuous improvement of theoretical knowledge and practical skills of employees. Moreover, experts are Neurosurgical Center of such courses for the exchange of experience and capacity not only in Germany but also in the best foreign medical institutions. Treatment of Cancer in Germany brain and many other diseases often carried out in close cooperation with other relevant departments highly specialized clinic of Duisburg. Among these branches can be noted and classical department neyropediatrii pediatrics, department of radiation therapy, neurology, neuroradiology.

Neurosurgery

Professor Cho received Ph.D, in physics, from Univ. of Uppsala, Sweden. Since then he has been faculty of UCLA, Columbia University, and University of California, Irvine. Last ten years, he served as a Director of the Neuroscience Research Institute, Gachon University and established one of the leading PET-MRI brain imaging centers in the world. Professor Cho is an early pioneer of CT and PET, developing world’s first circular ring PET (at UCLA, 1975) and BGO (PET-detector, 1976) and more recently 7.0T MRI+PET Fusion Brain Imaging System at NRI, in Korea. Currently Professor Cho is serving as a Distinguished Research Fellow at Seoul National University, Seoul, Korea, and also as a member of National Academy of Medicine, Washington D.C. USA.

Neurology

Dr. Huniades Urbina Medina is currently the President of the Venezuelan Society of Childcare and Pediatrics. He got Doctor of Medicine from University of Zulia in 2005. Disaster Management Course of natural causes, of war and terrorism: Focused on children and their families. University Hospitals of Cleveland . Latin American Association of Pediatrics. Panama, 13 to 17 November 2003. He has done training in Emergency Medicine, Sackler University, Tel-Aviv, Israel, 1996.

Pediatrics

Georgios M. Hadjigeorgiou EDUCATION/TRAINING: Medical School of National and Kapodistrian University of Athens, Greece (1983-1989). Degree: MD and PhD Thesis (1999) ïŸï€ Red Cross Hospital, Department of Neurology, Athens, Greece, Residency (1990-1995). Degree: Specialist in Neurology, University of Milano, Department of Neurology, Division of muscle Diseases, Milano, Italy. Research Fellowship (1996-1997). Genetics of metabolic myopathies ïŸï€ Columbia University Medical Center, Department of Neurology, Research Center for Muscular Dystrophy and Related Diseases, NY, USA. Research Fellowship (1998 and 2000). Genetics of metabolic myopathies and mitochondrial encephalomyopathies POSITIONS AND HONORS 1981-1983 Military Service; Officer Cyprus Army 1990-1995 Neurology Residency – employed by Greek government 1995-1996 Primary Care in rural areas – employed by Greek government 2000- 2002 Lecturer in Neurology, School of Medicine, University of Thessaly, Greece 2002-2008 Assistant Prof. Neurology School of Medicine, University of Thessaly, Greece 2008-2012 Associate Prof. Neurology School of Medicine, University of Thessaly, Greece 2012-now Prof. Neurology School of Medicine, University of Thessaly, Greece 2008-now Director of Sector of Neurology & Sense Organs, University of Thessaly, Greece 2005-now Member of Genetic Epidemiology for Parkinson\s Disease Consortium (GEO-PD) 2004-now Member of the European Restless Legs Syndrome Study Group (EURLSSG) 2010-now Member in Large of the EURLSSG Executive Committee 2007-now Head of Laboratory of Neurogenetics, BIOMED, CERETETH, Larissa, Greece 2012-now Member of ECTRIMS

Genetic basis and epidemiology of myopathies including metabolic myopathies, mitochondrial encephalomyopathies, muscular dystrophies, etc.,Genetic basis and epidemiology of Neurodegenerative Diseases including Parkinson’s Disease, Alzheimer’s Disease, Stroke, Motor Neuron Disease, etc.,Contribution of genetic factors in immune-pathogenesis of Multiple Sclerosis,Restless Legs Syndrome ïŸï€ Genetics of traumatic brain injury

Dr. Uthman, who received his M.D. from the American University of Beirut, has been a faculty member at Weill Cornell Medical College in Qatar (WCMC-Q) since 2008. Prior to joining WCMC-Q, Dr. Uthman served as faculty member at the University of Florida, Gainesville, Florida, Departments of Neurology, since 1991 and Neuroscience since 1996. Dr. Uthman has taught medical and graduate courses in neurology, epilepsy and electroencephalography (EEG).

Dr. Uthman’s research interests include clinical studies in the treatment of epilepsy, pharmacokinetics of antiepileptic drugs, seizures in the elderly, treatment of acute seizure disorders and status epilepticus and neurostimulation for treatment of epilepsy.

Rodney O. Leacock, M.D., neurointensivist at Palmetto Health Neurosurgery Associates, is board certified in neurology, neurocritical care and vascular neurology. Leacock received his medical degree from Howard University College of Medicine in Washington, D.C. and completed his neurology residency at Temple University Hospital in Philadelphia, Pennsylvania. He went on to complete a fellowship in neurocritical care at Wayne State University, Detroit Receiving Hospital in Detroit, Michigan and a stroke fellowship at Saint Louis University in Saint Louis, Missouri.

His clinical interests include acute ischemic stroke, intracranial and subarachnoid hemorrhage, status epilepticus, and airway protection in patients with neurological disorders. He specializes in caring for patients with complex neurological diseases.

Dr. Garcia joined Carilion in 2008 and was promoted to Section Chief of Body Imaging in 2009. She was appointed to her current position in 2011. Her major responsibility is to ensure clinical quality and safety for patients and staff. Prior to joining Carilion, Dr. Garcia was on staff at Pioneer Valley Hospital in West Valley City, Utah. She has given several presentations on radiology, imaging, radiation doses and advanced cardiac imaging with multi-detector CT. During her time at the University of Utah, she was the fourth-year Radiology Clerkship Director for the University of Utah School of Medicine. She holds medical licenses in Utah, Illinois, New Mexico and Virginia. Based on her outstanding academic performance in medical school, Dr. Garcia was inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Garcia enjoys collaborating as a member of the multi-disciplinary TAVR team.

Neurology, Stroke, Neuroimaging

The Director of the Institute is Professor Pankaj Sharma. In addition to being its director he is also a consultant neurologist at Imperial College Healthcare NHS Trust. Professor Sharma holds a University of London Chair of Neurology at Royal Holloway. He is a former British Heart Foundation Clinician Scientist at Cambridge and a Fulbright Scholar at Harvard Medical School. He holds double doctorates from both the University of Cambridge and University of London. Most recently he led the internationally renowned Imperial College Cerebrovascular Research Unit at Imperial College London.

Professor Sharma’s research seeks to use genetics, genomics and proteomics to advance human understanding of cerebrovascular disease in three key areas: prediction, diagnosis and treatment of stroke at the molecular level. He has a particular interest in the genetics of stroke in ethnic minorities, particularly South Asians and Middle Eastern populations

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU. His research focuses on a new derivative peptide of Amyloid beta for use as immunotherapy or vaccine that trains the immune system to recognize and remove amyloid-beta in the brain as well as on a novel therapy targeting one of the major hallmarks of Alzheimer’s disease, Neurofibrillary tangles. He was an integral part of the group at NYU who developed the first vaccines (active and passive immunization) targeting tau pathology in animal models of AD. More recently, he explores the possible therapeutic potential effect of the Stem Cell in AD mouse models. He is now focusing on the development of a new therapy and immunotherapy targeting Alzheimer’s disease and other related disorders such as prion, stroke and brain Injury.

George Perry is dean of the College of Sciences and the Semmes Foundation Distinguished University Chair in Neurobiology at The University of Texas at San Antonio. Dr. Perry is recognized in the field of Alzheimer’s disease research particularly for his work on oxidative metabolism. Dr. Perry is distinguished as one of the top Alzheimer’s disease researchers with over 1,000 publications, and one of the top 100 most-cited scientists in neuroscience and behavior (Over 68,000 citations, H=131), as well as the Expertscape Leading Expert in Alzheimer’s disease. Perry serves as editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease. He is a fellow of the American Association for the Advancement of Sciences, Texas Academy of Sciences, and Microscopy Society of America, a Fulbright Senior Specialist, as well as a member of the Dana Alliance for Brain Initiatives. Perry is also recognized internationally: he is a Foreign Member of the Spanish Royal Academy of Sciences, the Academy of Science Lisbon, and the Mexican National Academy of Sciences. He is also a recipient of the National Plaque of Honor from the Republic of Panama Ministry of Science and Technology

Dr. Perry’s studies are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. The lab has shown that oxidative damage is the initial cytopathology in Alzheimer disease. They are working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. Current studies focus on the: mechanism for RNA-based redox metal binding consequences of RNA oxidation on protein synthesis rate and fidelity role of redox active metals in mediating prooxidant and antioxidant properties signal transduction pathways altered in Alzheimer disease that allow neurons to evade apoptosis mechanism of phosphorylation control of oxidative damage to neurofilament proteins

Dr. Giulio Maria Pasinetti, The Saunders Family Chair and Professor of Neurology, received an M.D. from the Milan University School of Medicine and a Ph.D. from the University of Milan. He is currently the Director of the NIH funded Mount Sinai Center on the Promotion of Cognitive and Psychological Resilience and the Chief of the Brain Institute Center of Excellence for Novel Approaches to Neurodiagnostics and Neurotherapeutics. He is also a Professor of Psychiatry, of Neuroscience, and of Geriatrics and Adult Development. Dr. Pasinetti is the recipient of several academic awards including the prestigious Zenith and Temple awards from the Alzheimer's Association. Most recently, Dr. Pasinetti was awarded ''The Faculty Council Award'' for academic excellence at Mount Sinai School of Medicine and "The Charles Dana Alliance for Brain Research Award" from Dana Foundation, recognizing productivity and worldwide leadership in his field of expertise, which further emphasizes his standing as an academic role model.

Alzheimer's Disease Amyotrophic Lateral Sclerosis Diabetes Genomics Memory Obesity Parkinson's Disease

Giovanni Antioco Putzu is a Medical Doctor since 1992, with specialization in Paediatric Neurology. He achived his PhD in 1996. During PHD studies, He was a Research Fellow in Hammersmith Hospital of London, UK in 1992, then He moved in Marseille to work at INSERM (Genetics) and in Neurophathology. The Author has published more than 15 papers in the field of Neuromuscular Disorders.

Neurology, Neuromuscular Disorders

Superintendent of Yumin General Hosptial Co-Director Department of Neurology Changhua Chrisitian Hosptial National Delegate of Taiwan Neurological Society 18th President of Taiwan Neurological Society

Neurology

Walter Bini has completed his diploma from Westminster School, Simsbury Conn. U.S.A. and got postgraduate degree from Universidad de Zaragoza , Facultad de Medicina, Zaragoza-Spain. In 2014 he was the Middle East Chairman of ISLASS. He was Head of Neurosurgery, Sheikh Khalifa General Hospital , UAQ-UAE from 2014-2016. Currently he is Consultant Neurosurgeon, Orthopedic Department, spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also Visiting Consultant Neurosurgeon, Orthopedic Department of Healthpoint Hospital in Abu Dhabi - UAE.

Neurology And Neurosurgery

Prof. Radu Mutihac is Chair of Medical Physics Section, University of Bucharest, and works in Neuroscience, Signal Processing, Microelectronics, and Artificial Intelligence. As postdoc/research associate/visiting professor/full professor he run his research at the University of Bucharest, International Centre for Theoretical Physics (Italy), Ecole Polytechnique (France), Institut Henri Poincare (France), KU Leuven (Belgium). Data mining and exploratory analysis of neuroimaging time series were addressed during two Fulbright Grants in Neuroscience (Yale University and University of New Mexico). His research in fused biomedical imaging modalities was carried out at the Johns Hopkins University, National Institutes of Health, and Walter Reed Army Institute of Research, MD, USA. Prof. R. Mutihac is member of the ISMRM, ESMRMB, OHBM, Romanian US Alumni Association, and fellow of Signal Processing and Neural Networks Society IEEE, as well as referee for several journals of the Institute of Physics (London, UK), Neural Networks (Elsevier), IEEE Transactions on Image Processing, and evaluator/expert for the ISMRM, OHBM, ARACIS, CNCSIS, UEFISCDI, The Romanian � U.S. Fulbright Commission. and the European Commission (FP7, H2020). He published over 100 scientific papers, 12 monographs, and contributed with chapters in other 10 text books. He contributed to more than 150 scientific meetings with posters and oral presentations, seminars, invited and plenary lectures, as well as acting as organizer, chairman, and keynote speaker

Signal Processing, Microelectronics, and Artificial Intelligence

Alok Sharma is a Neurosurgeon and presently Professor & Head of Department of Neurosurgery at the LTMG Hospital & LTM Medical College, Director of the NeuroGen Brain & Spine Institute and Consultant Neurosurgeon at the Fortis Hospital in Mumbai , India. He has authored 12 books, edited 2 books, contributed chapters to 8 other books and has 83 scientifi c publications in medical journals. He has made 146 scientifi c presentations all over the world & has conducted several national and international trials and has been conferred with numerous honors and awards in his distinguished career. He has organized many international and national conferences and regularly conducts handson training workshops on Microvascular Surgery, Neuroendoscopy and Spinal fi xations. He has been committed to both basic as well as clinical research in attempting to fi nd an answer to the problems of paralysis and neurological defi cits that occur following injury and diseases of the nervous system. Is the pioneer of Stem cell therapy in India and has setup the Stem cell and Genetic research laboratory at the LTMG hospital & LTM Medical College. He has also created the NeuroGen Brain and Spine institute which is India’s fi rst dedicated Stem Cell Therapy and Neurorehabilitation Hospital. He has published pathbreaking results of Stem Cell therapy in Pediatric Neurodevelopmental disorders such as Autism and Cerebral palsy as well as in other conditions such as Muscular dystrophy and Spinal cord injury. He is the founder of the “Indian Journal of Stem Cell Therapy” and on the editorial board of 4 other journals. He is the Founding President of the “Stem Cell Society of India” and the Vice President of the “International Association of Neurorestoratology”. His other special interests include Revascularization surgery for cerebral ischemia, Psychosurgery, Stereotactic surgery, Neuroendoscopy, Spinal surgery and Neurotrauma.

stroke, CNS, Neurosurgery

Dr. Ivan Gospodinov Milanov is Director & Professor at the University Neurological Hospital “St. Naum”, Department of Movement Disorders in Bulgaria. He is a President of the Bulgarian Neurological Society, Bulgarian Movement Disorders and Multiple Sclerosis Society, Bulgarian Headache and Pain Society etc. Dr. Milanov has published 400 scientific publications & 18 monographs, 24 Handbooks of Neurology. His Research interest includes movement disorders, multiple sclerosis, headache, pain, and clinical electromyography.

Movement disorders, Multiple sclerosis, Headache, Pain, and Clinical electromyography.

Dr. Arvind G Kulkarni heads the ‘Mumbai Spine Scoliosis and Disc Replacement Centre’ as a Consultant Spinal Surgeon at Bombay Hospital, Mumbai, one of the oldest and largest hospitals of India. He has a vast experience in spinal surgery having trained in some of the top spinal centres across the globe such as KEM Hospital Mumbai, National University Hospital Singapore, Westmead Adult & Children’s Hospitals, Australia, St George Hospital – Australia and Toronto Western Hospital & Hospital for Sick Children Canada. He is one of the pioneers of Minimally Invasive Spinal Surgery in India (introduced Micro-Endoscopic techniques using the MetrX system for the first time in India in 2007). He is also one of the pioneers of Artificial Disc Replacement (name mentioned in Limca Book of Records for performing the first Artificial Disc Replacement [ProDisc-L] in the country)

Spine, neurology, Neurosurgery

Dr.Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007.

Neurology, Neuroradiology, Epidemiology

Associate Researcher at Basic and Clinical Neurosciences Research Labor & Vice President of SMNPH

Neurology And Neuroscience

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Geriatric Psychiatry, Addictions and Neuropsychiatry and Stroke Disorders

Raymond Sekula, Jr., MD, joined the Department of Neurological Surgery on March 1, 2013 as an associate professor and director of the department’s Cranial Nerve Disorders program. Dr. Sekula is known internationally and nationally for his development of microvascular techniques, which provide patients with improved outcomes, reduced complications, and easier recoveries. He has been recognized with numerous honors, including The American Association of Neurological Surgeon’s Young Investigator Award, The Trigeminal Neuralgia Association Fellowship Award, and Pittsburgh Magazine’s “40 Under 40” and “Best Doctor’s” Award.

Trigeminal neuralgia, hemifacial spasm; skull base tumors, minimally invasive brain surgery.

She works as a medical neurophysiologist attached in the department of neurosurgery at the Hospital de la Santa Creu i Sant Pau (Barcelona ) , and mutual Terrassa , providing its services also through Neurotoc to patients via mutual or private .

Neuromonitoring, Neuroimaging , Neurology

Dr. Roberto Federico Villa is an Associate Professor of Pharmacology of the Department of Biology and Biotechnology at University of Pavia (Italy) for degree in Biological Sciences and Chemistry. He is Doctor in Biological Sciences (D.Sc.), Medicine and Surgery (M.D.) Dr. Villa’s research interest on Physiopathology and Pharmacology of Central Nervous System Diseases (Aging, Hypoxia, Ischemia, Hyperammoniemia, Hypoglycemia, Depression, Parkinson) and drug’s interference on cerebral Bioenergetics and Molecular Medicine, by Functional Proteomics and Metabolomics of enzyme systems and on Dementia patients.

Dr. Villa’s research interest on Physiopathology and Pharmacology of Central Nervous System Diseases (Aging, Hypoxia, Ischemia, Hyperammoniemia, Hypoglycemia, Depression, Parkinson) and drug’s interference on cerebral Bioenergetics and Molecular Medicine, by Functional Proteomics and Metabolomics of enzyme systems and on Dementia patients.

Accomplished leader with significant experience as researcher, professor and consultant in Drug Discovery and Academia. Significant contributions to discovering drugs, to increasing the understanding of drug action and to the biology of several diseases. Strong scientific, management and communication skills demonstrated in all endeavors. Established track record of building functional, cohesive research teams that are empowered to meet and exceed research goals. Specifics include: --25 years in Drug Discovery functioning as research team leader in developing and executing research strategies from target discovery to drug screening and target validation in disease to marketed drug and post-market drug scientific support; History of maintained/consistent research/resource support in industrial environment for disease target research and compound progression in Discovery Research. --Significant experience as consultant to Pharmaceutical Companies, and in the academic work environment helping to developing research direction, helping to secure federal research grant support and teaching. --Ability to Integrate Systems Pharmacology/Biology and Translational Medicine into Drug Discovery and Disease Biology Research. --Long standing research background/experience in cardiovascular and cerebrovascular diseases. --Member of journal editorial boards and NIH study groups; scientific reviewer to many journals, granting organizations and study groups/sections; member of numerous scientific societies; four faculty appointments; currently have published over 200 scientific manuscripts, reviews, chapters and patents.

Basic scientific study of Cerebrovascular diseases with focus on stroke, vascular cognitive impairment, risk factors, brain injury and restoration of function, and progression to dementia Development of animal models of human disease that can translate well to man and can facilitate our understanding of disease biology, pathology and cellular signaling Investigation of pharmacologic and other intervention approaches that reduce brain injury and restore lost brain functioning Pursue Biomarker Discovery required to impact drug discovery and advance therapeutic interventions Maintain close collaborations with Clinical Researchers and Neuroscientists in efforts to support Translational Medicine

Patricio F. Reyes, MD is a board certified Neurologist and Neuropathologist, and director Barrow Neurological Institute’s Alzheimer’s disease (AD) and Cognitive Disorders Program, and Neuropathology Research Laboratory. Before joining BNI he was professor of Neurology, Pathology and Psychiatry and director of Creighton University’s Center for Aging, Alzheimer’s disease and Neurodegenerative Disorders, and Brain Bank and held similar positions at Jefferson Medical College in Philadelphia. He is the American Academy of Neurology advocate for Minority Americans with AD and other dementias. His interests include characterizing the clinical manifestations of Alzheimer’s disease and other dementias, and investigating the structural, anatomical and neurochemical substrates of neurobehavioral symptoms. He is involved in clinical trials for AD and has established clinical programs for Hispanic patients and minority caregivers. These programs are important in identifying ethnic related risk factors for AD, understanding the vulnerability of brain regions affected in AD, and verifying the safety, tolerability and efficacy of pharmacologic agents in various races. In the laboratory, he is currently involved in verifying the histological, immunohistochemical, electronmicroscopy, and metabolic changes in the brain parenchyma of triple transgenic mouse model of Alzheimer’s disease and Acetylcholinesterase knockout mouse. We expect to determine early physiologic and ultrastructural alterations that lead to neuronal loss and formation of neuritic plaques, and neurofibrillary tangles, and hope that our data will be relevant to the development of more effective therapies in AD.

Neurology

Born in Jammu-Tawi, India. After receiving Bachelor’s degree in Pharmaceutical Technology from the Birla Institute of Technology, Pilani, India, Rameshwar K. Sharma in 1960 entered the University of Connecticut for graduate work in Medicinal Chemistry and received his Ph.D. in 1963. Subsequently, after several Post-doctoral positions, including at the Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts, he joined the University of Tennessee Medical Center at Memphis in 1970 where he rose to the rank of Full Tenured Professor of Biochemistry and Physiology. During this period through NIH Special Fellowship he spent two-years Sabbatical as a Visiting Professor at the McArdle Laboratory University of Wisconsin, Madison, in Dr. Henry Pitot’s lab, and subsequently additional two-years Sabbatical at the NIH, Bethesda in Dr. Michael Cashel’s lab. After Full Professorship at the Case Western University and Founder and Head of the Unit of Regulatory Biology at the Cleveland Clinic Foundation, Cleveland Ohio, he joined the University of Medicine and Dentistry at New Jersey as the Professor and Head of The Unit of Regulatory and Molecular Biology. Since July 2006 he is at the Salus University as a Distinguished Professor of Biochemistry and Molecular Biology. In a period spanning four decades, his research team has dedicated itself to the advancement of the field of membrane guanylate cyclase in the vertebrate systems. A few of its core findings that have impacted this and the field of cellular signal transduction follow. (1) With the discovery of the first membrane guanylate cyclase, ANF-RGC that was also the hormone receptor of ANF, the membrane guanylate cyclase surface receptor family was established. (2) It had a unique signal transduction mechanism. Instead of GTP in G-Protein signaling, it was regulated by ATP through its ARM module (ARM). The complete dissection of the module, followed through the concept-based analysis, localized a WTAPELL motif that controlled the entire signal transduction process, it was, then, predicted that this motif is the one that controls the ANF-RGC-dependent blood pressure in vasculature. This has now been proven true through the construction of the mouse genetic model. The mice lacking this motif are hypertensive. (3) The discovery and molecular characterization of the photoreceptor ROS-GC is a land mark event in the phototransduction field. It filled in the gap on the identity of the source of cyclic GMP that serves as a second messenger of the LIGHT signal; and made it possible to explain the principles of phototransduction in molecular and physiological terms. It also impacted the core membrane guanylate cyclase field by branching it into two: a transducer of both the hormone receptor and the intracellularly-generated Ca2+ signals. (4) ROS-GC field took additional direction when it was demonstrated that, besides phototransduction, it is biochemically linked with the transduction mechanisms of the inner segments of the retina, olfactory cilia and the olfactory bulb neurons. (5) The demonstration that ROS-GC is a Ca2+-bimodal switch, generated a new revolutionary concept where theoretically ROS-GC could be modulated through two different modes of Ca2+ signaling: via Ca2+-sensor GCAPS and S100B, the latter stimulating it and the mode found exclusively in cones and absent in rods. (6) Recently, an additional model of the photoreceptor ROS-GC1 has been disclosed. ROS-GC1 is responsive to the bicarbonate signal; it is not the pH effect, rather it binds to a specific motif of the ROS-GC and transduces the signal in generation of cyclic GMP. Preliminary findings suggest that this novel transduction system is present in a small number of mouse cones, and, importantly, is absent in the rods. This opens up a new area of sensory transduction mechanism, where it is meant to communicate with the external atmospheric carbon dioxide. The carbon dioxide is sensed through carbonic anhydrase, whose subtype has been detected in some cones, it converts CO2 to the bicarbonate, which, then, becomes the second messenger of CO2 and a signaling agent of ROS-GC1. Threaded through this past history and step-by-step gain in the field, This investigator feels fortunate that his group has made these important contributions in generating the field of membrane guanylate cyclase, establishing that cyclic GMP is an ubiquitous intracellular second messenger in prokaryotes and eukaryotes and that it plays a critical role in the control of physiological processes of cardiac vasculature, smooth muscle relaxation, blood volume, cellular growth, sensory transduction, neural plasticity, learning and memory. It is also gratifying to know that during this course he has been able to train and guide more than 35 doctoral and post-doctoral students, author 184 peer-reviewed research articles, including the editorship of three books, Special Editorship of two journals of Molecular and Cellular Biochemistry and the e-book editor of the Frontiers Molecular Neuroscience Research Topic, all focused on the field of membrane guanylate cyclases. At present I am on the editorial board of four international journals: Associate editor of the Frontiers in Molecular Neuroscience, Journal of Molecular and Cellular Biochemistry, Journal of Signal Transduction, Journal of Membrane Science & Technology.

Membrane guanylate cyclase in the vertebrate systems

Dr. Ivan Gospodinov Milanov is Director & Professor at the University Neurological Hospital “St. Naum”, Department of Movement Disorders in Bulgaria. He is a President of the Bulgarian Neurological Society, Bulgarian Movement Disorders and Multiple Sclerosis Society, Bulgarian Headache and Pain Society etc. Dr. Milanov has published 400 scientific publications & 18 monographs, 24 Handbooks of Neurology. His Research interest includes movement disorders, multiple sclerosis, headache, pain, and clinical electromyography.

Movement disorders, Multiple sclerosis, Headache, Pain, and Clinical electromyography.

Dr. Hallowell served more than eight years as Associate Dean for Research and Sponsored Programs in Ohio University’s College of Health and Human Services and six years as Director of the School of Hearing, Speech and Language Sciences. Given her extensive experience in boosting successful publication and extramural funding successes of students and faculty members, she is frequently invited to provide action-focused workshops on research career development and on ways to foster productive interdisciplinary and international collaboration in research and education.

Neurogenic Language Disorders, Global Health, Technology Transfer, Engaged Teeaching/Learning Methods

Dr. Jasem Y Al-Hashel MD, FRCPC, FAHS. He is Consultant Neurologist and Chairman of Neurology Department, Ibn Sina Hospital he is also working as assistant Professor of Neurology, Faculty of Medicine, Kuwait University.He is also President, Kuwait Neurological Society Kuwait .

Neurology And Neuroscience

neurosurgeon barcelona fernando muñoz Dr. Fernando Muñoz Hernández Currently Attending Physician of the Neurosurgery Service of Hospital Santa Creu i Sant Pau . Tutor teaching. Secretary of the Skull Base Unit of the same hospital. Private practice in Clinical Teknon and Hospital de Barcelona since 2005 with Dr. Joan Molet (Head of Service of Hospital Santa Creu i Sant la Pau) Guards located at Hospital de Barcelona (Assistència Sanitària Col.legial) Bachelor of Medicine and Surgery from the Autonomous University of Barcelona ( Honours ) Specialized in neurosurgery as neurosurgery residency program (MIR) at the Hospital de la Santa Creu i Sant Pau and professor at the International University of Catalonia (UIC) . Observership in Department of Neurosurgery at the University of Miami with Prof. R. Heros External rotation in the Department of Neurosurgery at the Helsinki University Central Hospital in Finland Member and treasurer of the Catalan Society of Neurocirurgia Member of the Spanish Society of Neurosurgery Member and member of the Spanish Society of Skull Base Member of the Vascular Pathology of the SENEC active member of the Walter E. Dandy Neurosurgical Society. Member of the international AOSpine

Neurology And Neurosurgury

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU. His research focuses on a new derivative peptide of Amyloid beta for use as immunotherapy or vaccine that trains the immune system to recognize and remove amyloid-beta in the brain as well as on a novel therapy targeting one of the major hallmarks of Alzheimer’s disease, Neurofibrillary tangles. He was an integral part of the group at NYU who developed the first vaccines (active and passive immunization) targeting tau pathology in animal models of AD. More recently, he explores the possible therapeutic potential effect of the Stem Cell in AD mouse models. He is now focusing on the development of a new therapy and immunotherapy targeting Alzheimer’s disease and other related disorders such as prion, stroke and brain Injury.

2014 to continue member of Scientific Committee of European Academy of Neurology 2014 to continue member (European representative) at Teaching Course Committee, World Federation of Neurology 2013-2014 Rector of University of Medicine, Tirana Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. 2010-2013 Health National Contact Point, European Commission, CORDIS Fp7 programme 2003 to continue: reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. February 2003 to continue – Trainer of European Academy of Epilepsy. 1998-2007 - President of Albanian Society of Neurology (ASN). 1997 to continue - Head of the University Service of Neurology (UHC Mother Teresa of Tirana) (75 beds). 1981 to continue - Lecturer: Faculty of Medicine, Neurology Department. University of Tirana (University of Medicine since January 2013). Neurology

Neuroscience and Neurology

Dr. Sanjoy Sanyal, Associate Dean, Neuroscience and Clinical Professor in Texila American University, Guyana, is a surgeon by profession, medical academician and educator by choice and medical informatician from UK by aptitude and inclination. He has more than 2 decades of surgical experience and more than 17 years of teaching experience in hospitals and medical universities in 11 countries worldwide. He is also an Honorary Faculty, Editor and Peer-reviewer of Neuroscience in WebmedCentral. He was solely responsible for setting up the Neuroscience department in two medical schools in Seychelles and in the Caribbean. This included curriculum development, syllabus, labs and clinical training in Neurological Examination. Additionally, he was the sole faculty in charge of the Student Surgical Association and was responsible for establishing the format for surgical skills training in medical schools. With more than 400 online brain dissection and Neuroscience videos online, which have received thousands of subscribers, Dr. Sanyal is a prolific teacher. With more than 35 scientific print publications and 11 papers presented in international conferences, Dr. Sanyal is a keen academic researcher. Dr Sanyal developed a Digital Brain Imager which enables a researcher or student to view the internal structure of the human brain by taking transverse slices through the head at 10 mm intervals from the top of the skull to its base. Dr. Sanyal also developed an electronic computer-based system for quickly establishing the Anatomical Stage of 26 cancers of the human body with just 4 mouse clicks. He presented this paper in Medicine X Conference in Stanford University School of Medicine in September 2012. This earned him a Provisional Patent from the United States Patent and Trademark Office (USPTO) in January 2013 and 2014.

His research interests lie in Digital Brain Imaging Technologies, Brain Dissections, Brain Digital Videos and Imaging Informatics.

Dr. Marco Lopes has experience practicing counseling, psychotherapy and research in behavioral neuroscience. He works with individuals, couples and families. He tailors his approach to each person’s unique life situation, background, and goals taking an interactive and supportive cognitive approach with an emphasis on what works. Marco helps people cope with transitions, trauma and loss, overcome depression and anxiety from personal or work stress and develop a sense of meaning and direction in life. He also researches the evidence of neuroendocrine-immune system interactions (spleen, thymus, bone marrow and lymph nodes) and changes in brain functions affecting different immune responses for a new clinical approach which perceives and treats the patient as a psychic and somatic whole. Specialties: Specialist in neuroendocrinoimmunology - Tokyo Metropolitan Ohtsuka Hospital Master of Neuroradiology Interventionnelle - l'Hopital Pitie-Salpetriere in Paris Specialist in General Psychopathology - Naippe / Institute of Psychiatry - Hospital das Clinicas FMUSP

Neuroscience and Phenomenology,Neuroimaging of Bipolar Disorder,behavioral neuroscience

Stephen L. Nelson, MD, PhD, FAAP, is dual Board Certified in Neurology with Special Qualification in Child Neurology and in Psychiatry and Neurology by the American Board of Psychiatry and Neurology. He has over 15 years of experience in the field of Pediatric Neurology and Pediatrics. Dr. Nelson is the current Director of Pediatric Neurology at Tulane Medical Center in New Orleans, LA, where he performs high volume inpatient and outpatient evaluations. He runs the pediatric epilepsy center which offers video EEG monitoring as well as epilepsy surgery. Dr. Nelson is also a full-time Associate Professor of Pediatrics, Neurology, Neurosurgery, and Psychiatry at Tulane University School of Medicine. He holds a medical license in the states of Louisiana, Mississippi, and Maryland and is certified as a medical doctor expert witness by the state of Florida.

Dr. Nelson provides consultations based on his knowledge and experience as a high-volume child neurologist and a highly recognized expert in: Attention Deficit Disorder (ADD, ADHD) Autism Birth Asphyxia Brain Development Abnormalities Cerebral Palsy Developmental Delay Concussion Electroencephalography Epilepsy Genetic Disorders Erb's Palsy / Birth Injury Headache Disorders Hypoxic Ischemic Encephalopathy Infantile Spasms Movement Disorders Movement Disorders Muscle Weakness Myasthenia Gravis Pseudotumor Cerebri Seizures

Kaye studied Bachelor of Science – Nursing, at Curtin University and graduated as a Registered Nurse in 2008. Kaye currently works as Registered Nurse (part-time) looking after babies under 28 days at Neonatal Department at Princess Margaret Hospital for Children, Subiaco, Perth (WA). Her previous paediatric nursing experience includes working at the Emergency Department, Gastroenterology and Immunology Departments at Princess Margaret Hospital for Children. She has also worked for Edith Cowan University as a Paediatric Clinical Facilitator. Kaye commenced at Perth Paediatrics in 2016. She brings her skills and dedicated passion of working with children, to the first multi-specialty private paediatric clinic in Western Australia

Pediatric Nursing

Marina Reznik is Associate Professor of Pediatrics at the Albert Einstein College of Medicine and a General Pediatrician and a Child Health Researcher at Montefiore Medical Center. Her research focuses on development and evaluation of community-and school-based interventions to improve the health care services and outcomes for medically underserved minority children with asthma. She teaches and mentors medical students, residents and post-doctoral students, and provides clinical care to children from 0-21 years of age. She is an author of over 60 articles, book chapters and editorials and her research has been presented both nationally and internationally.

Pediatrics

Omer Ahmed has joined The American Hospital, Dubai (in 2009), after 15 years as a Consultant Paediatrician in UK. He is a Fellow of the Royal College of Physicians of Ireland and the Royal College of Paediatrics and Child Health UK. His Paediatrics training was in Sabah Hospital- Kuwait, Alder Hay Hospital-Liverpool, Great Ormond Street and The Royal Free Hospital in London before taking a Consultant post in Stevenage, Hertfordshire UK. Earlier in his career, Dr Ahmed has worked in Sudan, Libya and Kuwait. His experience covers wide areas in Child Health as a General Paediatrician. Dr Ahmed has several publications and presented/attended in several Paediatrics meetings and conferences.

Paediatrics

Ashutosh Kumar has completed his MBBS from Manipal University, India, Residency in Pediatrics from The Brooklyn Hospital Center, New York, USA and fellowship in Pediatric Neurology from University of Alabama at Birmingham (UAB), USA. He recently started working as a Assistant Professor in the Department of Pediatrics and Neurology at Penn State Milton S Hershey Medical Center. He is involved in multiple clinical trials as a Principal Investigator in Duchenne Muscular Dystrophy.

Duchenne Muscular Dystrophy in Children

Ozuah’s background includes a medical degree from the University of Ibadan, Nigeria, and a rotating internship at the University of Nigeria Teaching Hospital. He later earned a master’s degree in Education from the University of Southern California, Los Angeles, and a PhD in Educational Leadership and Administration from the University of Nebraska-Lincoln. He obtained his pediatric internship and residency at Albert Einstein College of Medicine and Montefiore Medical Center, and his post-doctoral research fellowship in Medical Education at the University of Southern California, School of Medicine, Los Angeles. Dr. Ozuah joined the faculty of the Department of Pediatrics at Montefiore and Albert Einstein College of Medicine in 1992 and served as director of the Residency Training Program in Social Pediatrics from 1999 to 2005.

Pediatrics

Suresh Kumar M.D. is Triple Board Certified Brain Injury Specialist, Neurologist & Director of Headaches, TBI & Memory Research Institute in Southern USA. He completed residency training in Neurology from LSU and later board certification in Headaches Medicine & Traumatic Brain Injury Medicine. He is User Interface Software Architect; Neuro Scientist & Clinician operating research based clinical practice. He has invented and patent rights owner of Life Integrated Cognitive Computerized Application (LICCA). His patients are undergoing online cognitive therapy for memory loss monitored from his own office Regain Memory Center. He has helped more than 50 patients with memory impairment after TBI, and mild to moderate dementia under Regain Memory 360 protocol approach.He has published and presented many abstracts and papers on diagnosis,treatment of mild traumatic brain injury and cognitive deficit.

TBI, Neurology , mild traumatic brain injury, late post-traumatic seizures, post-traumatic headaches,cognitive loss, plasticity and remediation.

Dr. Rosi is an Associate Professor in the Departments of Physical Therapy and Rehabilitation Science and Neurological Surgery; she is also the Director of Neurocognitive Research in the Brain and Spinal Injury Center (BASIC). Her areas of expertise include neuroinflammation, brain injury and cognitive functions. She obtained her PhD from the University of Florence, Italy. After completing a short Post-Doctoral Training in Italy she moved to the University of Arizona for a Post-Doctoral Research Associate position in the Neural System Memory and Aging Center under the guidance of Drs. Carol Barnes and Gary Wenk. She joined the UCSF faculty in 2006 and she received an accelerated promotion to Associate Professor in 2011 and became Director of Neurocognitive Research. She has been able to build national and international recognition in the field of Neuroscience, and among her numerous achievements she recently received the Bridging the Gap Award from the California Institute for Quantitative Bioscience (2015) and was chosen to give the 2015 Discovery Talk at the upcoming UCSF Alumni Weekend.

Neuroinflammation Traumatic brain injury Therapeutic cranial irradiation and cognition Space irradiation and cognition Innate immune system and cognition Synaptic plasticity, hippocampal learning and memory Plasticity-related immediate early gene Arc (activity regulated cytoskeleton-associated protein) Tumor Necrosis Factor-(TNF-α), learning and memory Prefrontal cortex injury and cognitive functions

Robert Friedlander, MD, MA, became the fourth chair in the department’s history. Prior to joining the department, Dr. Friedlander was professor of neurosurgery at Harvard Medical School and vice-chairman of neurosurgery and associate director of cerebrovascular surgery at Brigham and Women’s Hospital in Boston.

Aneurysms, vascular malformations, brain tumors, carotid disease, cerebrovascular disease, Chiari malformation, spinal cord tumors. Research focuses on mechanisms of apoptosis, Huntington’s disease, ALS, and stroke.

He is research at American Spine and Director General of the Federal Hospital of State Servers at the General Director of the Hospital. He is Former Physician at Multidisciplinary Center for Pain ,Former Physician at Ministry of Health - HFSE and Former Physician at Neurosurgery Former Physician at Forensic Medicine. He is also Former Physician at SBED - Brazilian Society for the Study of Pain

Spin, neurosurgery, pain

Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration.

Parkinsion’s and Alzheimer’s Diseases

Dr. Aguinaldo Pereira Catanoce is currently working as a Director in the University Hospital Technical Puc Campinas at Sao Paulo, Brazil. 1. Neurosurgeon Doctor With Expertise In Brain Tumors In areas Vascular Diseases, Surgery The Spine and Peripheral Nerves. Specializing In Video Endoscopic Surgeries For nervous system tumors, mostly Pituitary lesions 2. Medical Doctor In Neurosurgery. Especialized In Brain Tumors, Vertebral, Periferic Nerves And Vascular Desiese. Endoscopic Pituitary Adenomas For Video Neurosurgery And Ventricular Lesion 3. Expertise in Private Hospitals of. Assistant Team Neurosurgery From Vera Cruz Campinas Hospital, Campinas From From Puc Hospital and State Hospital Sumaré 4. Manager Administrative Medical. Manager Sector From Medical SADT Do Puc Campinas From Hospital. Manager Responsible For Medical Radiology In areas, hemodynamics, pathology, LAC, Endoscopy, Dialysis, Oncology Multidisciplinary Team and Hearing Health 5. Medical Manager Of Radiologic And therapeutic Area Of pontificie University Catolic Of Campinas Hospital. Oncology, Hemodialysis, Hemodinamic And Clinic Laboratory Medical Doctor Manager 6. Teacher of Medicine University Catolic Of Campinas, Brazil 7. Member of the Brazilian Society HOLDER Neurosurgery

Brain Tumors, Neurosurgery, Vascular Diseases, Spine and Spinal Disorders, Neurology

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong. Research Interest

Geriatric Psychiatry, Addictions and Neuropsychiatry and Stroke Disorders

Dr. Bielekova received an M.D. degree in 1993 from Comenius University in Bratislava, Slovakia. After a medical internship at SUNY Downstate, Medical Center in Brooklyn and a neurology residency at the Boston University, she did 3 year postdoctoral research fellowship at the NIH/NINDS/Neuroimmunology Branch (NIB). She remained at NIB for additional 5 years as staff physician, focusing on development of novel therapies for multiple sclerosis (MS). In 2005 she became associate professor of neurology and director of the Waddell Center for MS at University of Cincinnati. In 2008 she moved back to NINDS as an investigator. Her laboratory is studying mechanisms of immunoregulation in humans and mechanisms of tissue injury in neuroimmunological diseases, such as MS. In addition, Dr. Bielekova is in charge of the clinical service of the Neuroimmunology Branch and is principal investigator on several innovative Phase I/II clinical trials and natural history protocols.

Neuroimmunological Diseases Unit (NDU) has two major areas of interest: First, we study mechanisms of immunoregulation in humans with special emphasis on immunoregulatory natural killer (NK) cells and IL-2/IL-2R system. We are investigating mechanisms that maintain immune tolerance (i.e. mechanisms that assure that immune system does not attack normal tissue) in healthy human subjects and in patients with multiple sclerosis (MS) a putative autoimmune disorder of the central nervous system (CNS). Second, we are interested to define targets of the immune response in neuroimmunological diseases, mechanisms that participate in CNS tissue destruction and to define in-vivo biomarkers that reflect prevailing mechanisms of CNS tissue injury in neuroimmunological diseases. Our laboratory focuses on human subjects and extensive functional in-vitro studies are complemented with in-vivo observations derived from Phase I/II clinical trials that target pathways/molecules of interest defined in the laboratory. This allows us to correlate therapy-induced changes on the immune system functions to neuroimaging and functional measures of neurological disability, providing in-vivo relevance for the observed biological alterations. Our long-term goal is to develop novel, potentially curative immunomodulatory therapies for MS and to develop neuroprotective strategies for neuroimmunological diseases. Furthermore, we strive to define and validate biomarkers indicative and predictive of therapeutic response to different treatment modalities.

Dr. Rong Fu Wang as Chief physician, Doctoral supervisor, is the Director and professor of Nuclear Medicine Department of Peking University Health Science Centre and Peking Univerisity First Hospital. He is a physician trained in France & with 6 years of experience in research, academic and clinical practice of diagnostic and therapeutic nuclear medicine. He got MD(Nuclear medicine) from Paris V, France in 1992, and Ph.D.(pharmacology) from Toulouse III, France in 1995. As editor in the Textbook of Nuclear Medicine, J Labeled Immuno & Clinic, Chin Cancer Imaging, et al., he is senior most faculty with Peking University in nuclear medicine with about 300 publications, 12 books, 8 Grants, 4 patents, “Honorary Award” from the Society of Nuclear Medicine in the USA in 1994. “Noninvasive Imaging of Human Telomerase Reverse Transcriptase (hTERT) Messenger RNA with 99mTcRadiolabeled Antisense Probes in Malignant Tumor” has received Editors’ Choice Award for one of the three best basic science manuscripts published in The Journal of Nuclear Medicine in 2007. Now he is member of SNM, EANM, Country Principals of China in ASNM, Vice President of Chinese Society of Nucl Med Equipment and Techniques, and Vice President of Nuclear Medicine and Molecular Imaging in Beijing.

His special interest is in Nanomolecaular Imaging, Neuroreceptor and neurotransmission imaging, Nuclear Cardiology, Quality control of clinical muclear medicine and labeled compounds and radiopharmaceuticals.

Ivan Gospodinov Milanov is Director & Professor at the University Neurological Hospital “St. Naum”, Department of Movement Disorders in Bulgaria. He is a President of the Bulgarian Neurological Society, Bulgarian Movement Disorders and Multiple Sclerosis Society, Bulgarian Headache and Pain Society etc. Dr. Milanov has published 400 scientific publications & 18 monographs, 24 Handbooks of Neurology. His Research interest includes movement disorders, multiple sclerosis, headache, pain, and clinical electromyography.

Movement disorders, Multiple sclerosis, Headache, Pain, and Clinical electromyography.

Dr. E. Faizo. is a certified licensed Medical Doctor specialized in Neurosurgery and spine surgery practicing in Murnau Hospital south Germany. He presented in international seminars, media interviews and conferences in Health Care and education. Member of the Advisory boards in many German medical companies. Member of the German and European Neurosurgical Societies.

Spine surgery in research and pain therapy , Neuromodulation

Dr. Nino Devidze is the Director of Neuroscience Research, Gene Therapy Program in Perelman School of Medicine of University of Pennsylvania. She was the Principal Scientist at Bristol-Myers Squibb. And also she served as a Director of Neurobehavioral Core Laboratory at Gladstone Institute of Neurological Disease, San Francisco. She has received many awards and she published over 51 scientific abstracts.

Neuroscience, Gene Therapyand her current focus is developing AAV therapies for Neurodevelopmental Diseases

Dr. Alberto E. Musto, MD, PhD, FAES, is an Assistant Professor of Pathology and Anatomy, one of the Module Directors of the Pre-clerkship CareForward Curriculum, School of Medicine and Director of Neuroanatomy course, School of Health Professionals at Eastern Virginia Medical School in Norfolk, Virginia. Dr. Musto integrates an interdisciplinary approach in medical education and mentorship activities in neuroscience research to enhance research, and diversity in the new medical curricula. He has been bestowed with a prestigious award -- Fellow of the American Epilepsy Society (FAES) – a lifetime professional honor in recognition of his accomplishments and dedication to excellence in epilepsy. He has several publications in major journals in the field of neuroscience and epilepsy, including with his colleagues patents in neuroprotection and against glioblastoma multiforme development. He has been a member of NIH grant review study sections.

Interests: His primary research interest is to understand the immune-inflammatory process in the neural tissue following a brain injury that contribute to aberrant neuronal networks formations which mediate the development of epilepsy.

Jeffrey David Lewine, PhD is a Professor of Translational Neuroscience, and the Director of Business Development at the MIND Research Network in Albuquerque, New Mexico. He is also the Director of Neuroscience for Lovelace Scientific Resources; an adjunct associate professor in the departments of Psychology and Neurology at the University of New Mexico; the Director of Clinical Research for Cognionics Inc.; and the CEO of the Center for Advanced Diagnostics, Evaluation, and Therapeutics. Dr. Lewine received his doctorate in neuroscience in 1989 from the University of Rochester. Following completion of his graduate training, he was named a Director's Fellow at Los Alamos National Laboratory where he worked on the development of advanced brain imaging technologies. Dr. Lewine has previously directed functional brain imaging programs in New Mexico, Utah, Kansas, and Illinois, and his research uses advanced behavioral, psychophysical, imaging (MRI, fMRI, DTI, SPECT), and electrophysiological (EEG, MEG) methods to study brain structure and function in health and disease. Dr. Lewine evaluates human subjects and animal models to explore a wide range of clinical conditions including autism, dementia, epilepsy, reading disorders, schizophrenia, PTSD, and traumatic brain injury. These investigations include the development and evaluation of novel therapies and biomedical countermeasures, and they have been funded by the National Science Foundation, the National Institutes of Health, the Department of Energy, the Department of Defense, and the Biomedical Advanced Research and Development Authority. Dr. Lewine has directed functional brain imaging programs in New Mexico, Utah, Kansas and Illinois, and is the co-author of more than 100 peer-reviewed research articles and book chapters.

Autism, Traumatic Brain Injury, Post-Traumatic Stress Disorder, Tinnitus, Epilepsy, Neuro-Plasticity

Walter Bini has completed his diploma from Westminster School, Simsbury Conn. U.S.A. and got postgraduate degree from Universidad de Zaragoza , Facultad de Medicina, Zaragoza-Spain. Presently since 2014, Middle East Chairman of ISLASS. Active Member and Board Member of numerous international societies , among these : SAS, German Neurosurgical Society, AANS and the Skull Base Study Group. He was Head of Neurosurgery, Sheikh Khalifa General Hospital , UAQ-UAE from 2014-2016. Currently he is Consultant Neurosurgeon, Orthopedic Department, spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also Visiting Consultant Neurosurgeon, Orthopedic Department of Healthpoint Hospital in Abu Dhabi - UAE

Micro neurosurgery, special interest and expertise in the management of head trauma, neurooncology, stereotaxy and radiosurgery, spinal surgery including less invasive techniques and neuroradiology

Juan Cruz González is Clinical Psychologist and Consultant. Teacher of Master Universities in Comprehensive Psychological Intervention in Uncommon Diseases and In General Sanitary Psychology. He is also professor of postgraduate courses for Experts in Social Intervention in Alzheimer's disease and other dementias, as well as of Positive Psychology. He is author of the Guide of Psychological Support in Sclerosis Lateral amyotrophic ELA. Editorial Polibea and ADELA 1996. And co-author Support Guide Psychology for Rare Diseases, of the Spanish Federation of Diseases Rare FEDER. He is Honorary member of the Spanish Association of Lateral Sclerosis Amyotrophic ADELA 1995. Founder and former coordinator of the Working Group on Neurodegenerative and Rare Diseases of the Official College of Psychologists of Madrid, currently a member of the Intelligent Humor and Optimism Group (laughter therapy) of the COPM. He is part of the Advisory Committee in Spain: the European Project Generate Intergenerational Programs, University of Granada and Lifelong Learning Program Generate. Founder and director of DiotOcio from where he creates and Implants positive psychology programs -Optimismo, Nature Psycho Training, as well as Intergenerational and Inclusive

Psychology, Alzheimer's disease and dementia, Neurocognition

Dr. Miguel Angel Maroto Serrano is a Psychologist, Clinical and social Gerontology Expert in Active and Dementia Aging. He is the Coordinator and Professor of University Postgraduates Technical and Director of professional teams. He is the author of technical manuals on elderly people and dementias (8 works published by the Community of Madrid and Tea Editions)and Director and Manager at Clinical and Social Intervention Center and Ahoracentros

Psychology, Gerontology, Alzheimer's and Dementia

Lynne Hughes is vice president and global head of QuintilesIMS’ Neurology Center of Excellence (CoE), where she develops evidence-based strategies to conduct clinical programs for customers. She also leads the Autism CoE and the Acute Care and Pain CoE. Dr. Hughes has worked in the industry for more than 30 years, including 20 years at QuintilesIMS, and has worked both in Europe and the US. Lynne has worked exclusively in neurology while at QuintilesIMS and possesses expertise in all areas on Neurology, including Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, epilepsy, acute care and pain. Dr. Hughes has been involved in the clinical trial development of many of the neurological therapies on the market today. She is a member of a number of steering and executive committees for clients and has responsibility for several consultancy programs for investment opportunities within all areas of neurology. Dr. Hughes earned her bachelor’s degree in Medical Sciences from the University of Bradford in Bradford, England. She completed her Ph.D. in Oncology and Cancer Biology at the University of Birmingham, in Birmingham, England, fully sponsored by Cancer Research UK. In addition, she is certified as a Project Management Professional.

Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, Neuro-orphan diseases.

Dr. Drini DOBI was born in January 27th, 1969, and graduated as PhD in University of Tirana, Albania in 1992, and has done the specialization course in Neurology from 1994-1998 in University Hospital Centre "Mother Teresa", Tirana Albania. After his specialization, he has done some other minispecialization course for neurorehabilitation in Instituto Carlo Besta, Milano, Italy, San Carlo , Milan, Italy and Don Carlo Gnocchi Milano, Italy and minispecialization course for neurosonology in UHC "Sestre Milosrdnice" Zagreb, Croatia. He has a lot of publications in some medical periodics and has participated in some of AAN Annual Meetings with his works, EFNS and EAN conferences, with his works too, and some other Neurological Conferences abroad. His Masters is in Rehabilitation in Parkinson Disease, in 2005 and PhD in Physical Rehabilitation after stroke in 2015. He is also the Member of EAN Scientific Pannel of Neurorehabilitation ,Scientific Pannel of neurotoxicology, and General Neurology

Neurorehabilitation and Stroke

David has worked in community based mental health services in the UK for over thirty years developing services for people with complex care needs and enduring mental health problems in a career spanning the voluntary sector, local authority services, and the NHS.. From 2009 - 2011 he was the Dementia Implementation Lead for Commissioning Support for London, working with commissioners across London to improve dementia services. He is an independent writer and researcher on dementia support and services for Black and minority ethnic communities, working with a number of projects and initiatives.

Dementia, Mental Health

Dr. Majaz Moonis is a neurologist in Worcester, Massachusetts and is affiliated with multiple hospitals in the area, including Health Alliance Hospital and UMass Memorial Medical Center. He received his medical degree from Delhi University College of Medical Sciences and has been in practice for more than 20 years. Dr. Moonis accepts several types of health insurance, listed below. He is one of 24 doctors at Health Alliance Hospital and one of 81 at UMass Memorial Medical Center who specialize in Neurology.

My research focuses on several interrelated areas that affect stroke and dementia outcomes. More specifically I am interested in the following areas: Outcome research related to specific interventions affecting the vascular endothelium in stroke and Alzheimer’s disease; health care disparities relating to race, age and gender in stroke and dementia; optimal management and effects on primary and secondary stroke prevention; genetic markers in cryptogenic stroke to aid in sub-classification and management; clinical trials in acute stroke and stroke prevention; data mining in sleep related disorders; and stroke.

Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration

The major focus of this laboratory has been to study the mechanisms of topographic regulation of neuronal cytoskeletal proteins regulation by phosphorylation and neurodegeneration.

Dr Girouard completed her PhD in cardiovascular physiology in 2002 at the Université de Montreal under the supervision of Dr J. de Champlain, a specialist in the field of hypertension. She then pursued with two fellowships both on the study of cerebrovascular regulation: one at the Weill Medical College of Cornell University and a second one at the University of Vermont under the supervisions of Dr. Costantino Iadecola and Dr Mark T. Nelson, respectively. She is now associate professor at the Department of pharmacology and physiology at the Université de Montréal and the director of the laboratory of neurovascular pharmacology since 2008. Along her career, Dr Girouard received prices including the Merck New investigator price of the ‘Société Québécoise d’Hypertension Artérielle’ and the Young Investigator Award from the Heart and Stroke Foundation of Canada. She recently was nominated Fellow of the American Heart Association. She is involved in many Societies related to Hypertension and neurosciences in particular the ‘Société Québécoise d’Hypertension Artérielle’ and the ‘International Society of Cerebral Blood Flow and Metabolism’ in which she is member of the Board of Directors.

The research interests of Dr Girouard are the study of the mechanisms underlying cerebrovascular regulation in health and diseases especialy in the context of hypertension and arterial stiffness. The main objective of her research is to find therapeutical targets to protect the brain from vascular diseases. To reach this objective, she is using various techniques from molecular biology to brain imaging in mice and humans. She published mostly in the field of hypertension and cerebrovascular regulation.

Panteleimon Giannakopoulos has completed his MD at age of 23 years from the University of Athens and is board certified psychiatrist and psychotherapist from 1999. He completed his postgraduate training in London and Paris before taking the chair of old age psychiatry in Geneva. He has also a full training in cognitive neurosciences focusing on dementing conditions. He was the chairman of the Department of Psychiatry in Geneva from 2005 to 2015 before being appointed as medical director of the Forensic Psychiatry for the Geneva county. He has published more than 220 peer-reviewed articles (h index: 42), and has been serving as an editorial board member and reviwer of repute.

Identification of markers of cognitive decline in mild cognitive impairment, late-onset depression and bipolar disorders, Cognitive impact of vascular lesions in brain aging, Alzheimer’s disease (AD), Use of recombinant clusterin to prevent ischemic damage in organotypic cultures and after middle cerebral artery occlusion

Dr Meguro was educated at the Tohuku University at both undergraduate and post-graduate level. He obtained his PhD in Neurology and Geriatric Medicine. He has vast work experiences at the Centre-CYCERON-INSERM, in France and the ADRC, Washington University in St. Louis, School of Medicine. From 2005 till present, he is a Professor at the Department of Geriatric Behavioral Neurology, Tohoku University Graduate School of Medicine. He is board-certified by the Japanese Academic Societies in the specialty of Internal Medicine, Clinical Neurology, Stroke Medicine, Geriatric Psychiatry, Dementia Medicine. He sat on the editorial Board of prestigious journal such as the Alzheimer Disease Associated Disorders, Dementia & Neuropsychology and the International Journal of Alzheimer’s Disease

Dementia, Alzheimer's disease related disorders, Neuropsychology

Dr.Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007.

Neurology, Neuroradiology, Epidemiology

Dr Priya Sharda spent her formative years building her career in one of the largest bed occupancy hospital, Hospital Kuala Lumpur, Malaysia. After coming out as a Neurosurgeon from University Sains Malaysia (USM), she spent another year there before embarking into another era in the Northern region of Malaysia’s’ primary tertiary Hospital for Neurosurgery, Penang General Hospital. She has published a few papers in reputed journals along her way despite busy schedule. She is also a keen trainer and spends time teaching post basic nursing as well as medical students.

Pediatric Neurosurgery Stroke Surgery Traumatic Brain Injury Pediatric Neurosurgical Anomalies.Stroke

Dr. Mohammad Mohsin Ali Farazi was born in 13th march 1969 in Bagerhat district, BANGLADESH. He obtained his MBBS from Sher-E-Bangla Medical College, Barisal, BANGLADESH in January 1995. After completion of internship training he joined in Government service in 1997. He served many government hospitals with efficiency and dignity. He completed his post graduation MS (Masters of Neurosurgery) from Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka , BANGLADESH in July 2008. After that he posted as Junior consultant (Neurosurgery) in Shaheed Sheikh Abu Naser Specialized Hospital, Khulna, BANGLADESH. Now he is working as Assistant Professor (Neurosurgery) in the same hospital. He did many Neurosurgical procedures both emergency and routine. He attended in many national and International conferences in home and abroad. He presented scientific papers in many seminars and symposiums. His scientific papers published in many national and international journals. He is the life member of Bangladesh Medical Association (BMA), Society of Surgeons of Bangladesh (SOSB), Bangladesh Society of Neurosurgeons (BSNS) and NeuroSpine Society of Bangladesh (NSSB).

Spinal Neurosurgery

WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong

His main research areas are Neuropsychiatry in Stroke, Substance abuse, Postnatal depression, dementia, cognitive impairment, depression, anxiety, apathy, fatigue, emotional incontinence, suicidality, insomnia, pain, and quality of life. Other research areas include psychiatric morbidity in Pneumoconiosis and Parkinson’s disease, Electroconvulsive Therapy, Schizophrenia and Psychogeriatrics

Mohammad Nazrul Hossain, passed MBBS from Sir Salimullah Medical College, Dhaka, Bangladesh in 2000. He got his fellowship in Neurosurgery from Bangladesh College of Physician and Surgeons (BCPS) in 2012.He was the first fellow in his subject from BCPS.His study was acknowledged by the BCPS and published in their journal. After successful completion of his fellowship he joined and worked in a world renowned chain hospital “APOLLO”, Dhaka, Bangladesh as neurosurgeon. During his neurosurgical carrier he worked with famous neurosurgeons of both national and international level. He joined “Jalalabad Ragib-Rabeya Medical College and Hospital” from Apollo in 2013 and established a fully new Neurosurgery department and serving the people of this area with their satisfaction.

Neurosurgery,

Dr. Federoff will oversee and guide the development of UC Irvine Health. In addition to leading the School of Medicine, he will provide strategic direction for the clinical programs of UC Irvine Medical Center and all affiliated patient care centers and will ensure the alignment of the clinical enterprise and the physicians’ practice plan with the university’s academic and research missions. He will also provide guidance on the development and integration of UCI’s health-related academic programs in nursing science, public health and pharmaceutical sciences.

pharmaceutical sciences, nursing science

David has worked in community based mental health services in the UK for over thirty years developing services for people with complex care needs and enduring mental health problems in a career spanning the voluntary sector, local authority services, and the NHS.. From 2009 - 2011 he was the Dementia Implementation Lead for Commissioning Support for London, working with commissioners across London to improve dementia services. He is an independent writer and researcher on dementia support and services for Black and minority ethnic communities, working with a number of projects and initiatives.

Dementia, Mental Health

Perry received his bachelors of arts degree in zoology with high honors from University of California, Santa Barbara. After graduation, he headed to Scripps Institution of Oceanography and obtained his Ph.D. in marine biology under David Epel in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Dr. Bill Brinkley and Joseph Bryan at Baylor College of Medicine where he laid the foundation for his observations of abnormalities in cell structures. In 1982, Perry joined the faculty of Case Western Reserve University, where he currently holds an adjunct appointment. He is distinguished as one of the top Alzheimer’s disease researchers with over 800 publications, one of the top 100 most-cited scientists in neuroscience and behavior and one of the top 25 scientists in free radical research. Perry has been cited over 23,000 times and is recognized as an ISI highly cited researcher. Perry is editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease. He is a fellow of the American Association for the Advancement of Sciences and past-president of the American Association of Neuropathologists, as well as a member of the Dana Alliance for Brain Initiatives. Perry is recognized internationally for his work. He is a Foreign Correspondent Member of the Spanish Royal Academy of Sciences and a Foreign Member of the Mexican National Academy of Sciences, and recent recipient of the National Plaque of Honor from the Republic of Panama Ministry of Science and Technology.

Brain disorders, Dementia, Neurology and Neurosugery

Professor and head of department in Grant Medical College & Sir JJ Group of hospitals 1991-2002. Professor Emeritus - Grant Medical College & Sir JJ Group of Hospital September 2005 till date. National coordinator for World Federation of Neurology Education Continuum-CME programme since 2005. Member of the WHO International Advisory Group for the Revision of ICD 10, Diseases of the Nervous System in the area of Infections of the Nervous System - January 2010 Member - World Federation of Neurology Education Committee since 2010 till date. Chair - World Federation of Neurology Teaching Course Committee 2014.

Neurology and Neurosugery

Born in Jammu-Tawi, India. After receiving Bachelor’s degree in Pharmaceutical Technology from the Birla Institute of Technology, Pilani, India, Rameshwar K. Sharma in 1960 entered the University of Connecticut for graduate work in Medicinal Chemistry and received his Ph.D. in 1963. Subsequently, after several Post-doctoral positions, including at the Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts, he joined the University of Tennessee Medical Center at Memphis in 1970 where he rose to the rank of Full Tenured Professor of Biochemistry and Physiology. During this period through NIH Special Fellowship he spent two-years Sabbatical as a Visiting Professor at the McArdle Laboratory University of Wisconsin, Madison, in Dr. Henry Pitot’s lab, and subsequently additional two-years Sabbatical at the NIH, Bethesda in Dr. Michael Cashel’s lab. After Full Professorship at the Case Western University and Founder and Head of the Unit of Regulatory Biology at the Cleveland Clinic Foundation, Cleveland Ohio, he joined the University of Medicine and Dentistry at New Jersey as the Professor and Head of The Unit of Regulatory and Molecular Biology. Since July 2006 he is at the Salus University as a Distinguished Professor of Biochemistry and Molecular Biology. In a period spanning four decades, his research team has dedicated itself to the advancement of the field of membrane guanylate cyclase in the vertebrate systems. A few of its core findings that have impacted this and the field of cellular signal transduction follow. (1) With the discovery of the first membrane guanylate cyclase, ANF-RGC that was also the hormone receptor of ANF, the membrane guanylate cyclase surface receptor family was established. (2) It had a unique signal transduction mechanism. Instead of GTP in G-Protein signaling, it was regulated by ATP through its ARM module (ARM). The complete dissection of the module, followed through the concept-based analysis, localized a WTAPELL motif that controlled the entire signal transduction process, it was, then, predicted that this motif is the one that controls the ANF-RGC-dependent blood pressure in vasculature. This has now been proven true through the construction of the mouse genetic model. The mice lacking this motif are hypertensive. (3) The discovery and molecular characterization of the photoreceptor ROS-GC is a land mark event in the phototransduction field. It filled in the gap on the identity of the source of cyclic GMP that serves as a second messenger of the LIGHT signal; and made it possible to explain the principles of phototransduction in molecular and physiological terms. It also impacted the core membrane guanylate cyclase field by branching it into two: a transducer of both the hormone receptor and the intracellularly-generated Ca2+ signals. (4) ROS-GC field took additional direction when it was demonstrated that, besides phototransduction, it is biochemically linked with the transduction mechanisms of the inner segments of the retina, olfactory cilia and the olfactory bulb neurons. (5) The demonstration that ROS-GC is a Ca2+-bimodal switch, generated a new revolutionary concept where theoretically ROS-GC could be modulated through two different modes of Ca2+ signaling: via Ca2+-sensor GCAPS and S100B, the latter stimulating it and the mode found exclusively in cones and absent in rods. (6) Recently, an additional model of the photoreceptor ROS-GC1 has been disclosed. ROS-GC1 is responsive to the bicarbonate signal; it is not the pH effect, rather it binds to a specific motif of the ROS-GC and transduces the signal in generation of cyclic GMP. Preliminary findings suggest that this novel transduction system is present in a small number of mouse cones, and, importantly, is absent in the rods. This opens up a new area of sensory transduction mechanism, where it is meant to communicate with the external atmospheric carbon dioxide. The carbon dioxide is sensed through carbonic anhydrase, whose subtype has been detected in some cones, it converts CO2 to the bicarbonate, which, then, becomes the second messenger of CO2 and a signaling agent of ROS-GC1. Threaded through this past history and step-by-step gain in the field, This investigator feels fortunate that his group has made these important contributions in generating the field of membrane guanylate cyclase, establishing that cyclic GMP is an ubiquitous intracellular second messenger in prokaryotes and eukaryotes and that it plays a critical role in the control of physiological processes of cardiac vasculature, smooth muscle relaxation, blood volume, cellular growth, sensory transduction, neural plasticity, learning and memory. It is also gratifying to know that during this course he has been able to train and guide more than 35 doctoral and post-doctoral students, author 184 peer-reviewed research articles, including the editorship of three books, Special Editorship of two journals of Molecular and Cellular Biochemistry and the e-book editor of the Frontiers Molecular Neuroscience Research Topic, all focused on the field of membrane guanylate cyclases. At present I am on the editorial board of four international journals: Associate editor of the Frontiers in Molecular Neuroscience, Journal of Molecular and Cellular Biochemistry, Journal of Signal Transduction, Journal of Membrane Science & Technology. I am also the founding father and the President of the Guanylate Cyclase Innovative Biotechnology.

Neurology and Neuropharmacology

Claude M Wischik holds the Chair in Old Age Psychiatry at the University of Aberdeen in Scotland, and is Executive Chairman of TauRx Pharmaceuticals. He studied medicine in Australia, completed his PhD at the Laboratory of Molecular Biology in Cambridge, and also higher psychiatric training in Cambridge. He was the first to identify Tau protein as the main constituent of the Alzheimer tangle and developed the fi rst Tau Aggregation Inhibitors. He has published 121 papers and holds 11 patent groups based on his work with over 40 individual patents.

Alzheimer’s disease and Dementia

Professor of Neurosurgery in the Updating Course supported by the University of Bari and the Apulia Region “Patient Management: Interrelation between Medical Physicians and Healthcare givers,” University Hospital of Bari, Italy SURGICAL SKILLS AND EXPERIENCE Performed over 4,500 neurosurgical operations of the following types: -cranial traumas (950) -spinal cord traumas (500) -benign and malignant endocranial tumours (1100) -benign and malignant spinal cord tumours (400) -hemorrhagic vascular pathologies (400) -cerebral abcesses (60) -cerebral and spinal parasitosis (30) -pediatric neurosurgery (300) -functional neurosurgery (50) -cervical, dorsal, lumbar disk hernias and degenerative diseases (900) MAIN RESEARCH AND SCIENTIFIC SKILLS RESEARCH PROJECT FUNDS INTERNATIONAL JOURNAL REFEREE MAIN CONGRESS PARTICIPATION MAIN PUBLICATIONS MAIN PUBLICATION RECOGNITION AWARD

Cranio-spinal neurotraumatology with clinical and experimental research in traumatic patients. Spinal neurosurgery in degenerative diseases with decompression and stabilization as well as reconstructive techniques. Oncological neurosurgery (cerebral and medullary) with anatomo-pathological and genetic studies. Vascular neurosurgery in the treatment of vascular malformations and haemorrhages. Neurosurgery in cerebral and spinal parasitosis. Pediatric neurosurgery with studies in the treatment of childhood malformations, tumours and vascular pathologies of the brain and spine. Functional neurosurgery with the application of beta-ray sources and the Argon laser in stereotactic therapy of degenerative, vascular and tumour pathologies.

Graduated in Biological Sciences (D.Sc.) and in Medicine and Surgery (M.D.) - Associate Professor of Pharmacology at University of Pavia -Teaching Pharmacology for students in Biological Sciences and in Chemistry - Visiting: (1) Department of Neurology and (2) Cerebral Metabolism Research Laboratory, University of Lund, Sweden; (3) Department of Psychobiology, University of California ICI, U.S.A.; (4) Max Plank Institute for Neurochemistry, University of Gottingen, Germany; (5) San Diego Alzheimer’s Disease Research Center, University of California, San Diego, U.S.A.. Research activities: biochemical studies (Functional Proteomics and Metabolomics) on Physiopathology and Pharmacology of the Central Nervous System in experimental conditions of hypoxia, ischaemia, hyperammoniaemia, ipoglycaemia on the cerebral energy metabolism and actions of drugs on the brain energy state; molecular mechanisms of ageing and drugs' interference; the study of Parkinson’s disease and drugs' actions in Dementia; clinical studies on Molecular Medicine and Human Genetics on patients affected by neurological diseases (Dementia) or Alzheimer’s disease. Scientific research activity: 349 total papers: no. 129 on peer international reviews (IF about 350, only ISI publications); no. 66 Congress Proceedings and Acts; no. 154 communications in International Meetings, participating to no. 219 scientific Congress; officially invited to no. 214 Congress since 1993; from 2010 no. 56 as speaker; 9 Member of Organizing Committee or Session Chair/Co-Chair. International appointments as: (A) International ad hoc Reviewer for: - Research Founding Grants (Neuroscience) of The Wellcome Trust Foundation, London, United Kingdom (since 1994) - British Medical Council (asked 2014) inserted as - Reviewer’s Database for Founding of United Kingdom SBS, North Star House, Swinodon, U.K. - Listed as International Expert for the evaluation of Research Grant Programs of the European Commission Research Directorate General, Life Sciences: Health Research, European Union, Brussels. - Reviewer’s Database of Journal of Neuroscience - Reviewer’s Database of European Journal of Neurology And Committee Member of Italian Ministry for Scientific Research Grants (MIUR). (B) Member of the International Experts Panel of the Medical Science Monitor (since 2003), Albertson, New York, U.S.A. (C) Participant to ex Internship Program for U.S.A. students of New York Academy of Science, New York, U.S.A. Accredited Researcher for grants at National Institute of Health (NIH - U.S.A.). (D) Medical Credits at San Diego Alzheimer’s Disease Research Center Conference of University of California, San Diego, U.S.A. (E) Member of the Editorial Boards of: - Member of the Science Advisory Board – Arlington, U.S.A.. - Member of the Editorial Board of “Neurological Disorders & Therapy” – U.S.A. - VIP Member of EB of Neural Regeneration Research, Supervisor Ministry of Health - China (until 2013). - Member of EB of Journal of Neurological Disorders - Member of EB of “Aging and Neurodegeneration” – Anhui Medical University, China - Academic Editor of International Neuropsychiatric Disease Journal. - Member of EB of Journal of Depression and Anxiety – Los Angeles, California, U.S.A.. - Member of EB of International Journal of Emergency Mental Health and Human Resilience – Foster City, California, U.S.A.. - Member of EB of International Journal of Neurology Research – Sheung Wan, Hong Kong (China) - Member of EB of Journal of Neurology and Neuroscience – Wilmington City, Delaware, U.S.A.. (N) ad hoc Reviewer for over of 25 Journals: (in 1989) for Circulation Research; reviewer (from 1989) for Mechanisms of Ageing and Development; reviewer (in 2003) for Molecular Brain Research; reviewer (in 2004) of the Cochrane Dementia and Cognitive Improvement Group, Department of Clinical Gerontology, Oxford, U.K.; reviewer (since 2004) for Experimental Gerontology; reviewer (in 2004) for the “Bioastronautics Critical Path Roadmap Document”, Bioastronautics Research Division of NASA, U.S.A.; reviewer (since 2004) of The Journal of Clinical Pharmacology; reviewer (from 2011) of Complementary Medicine and Drug Discovery; reviewer (in 2011) for Drugs Today, Prous Thomson Reuters; reviewer (in 2011) for Neuropharmacology, Vascular Pharmacology, Journal of Neurological Disorder; reviewer (in 2012) for Vascular BMC Neurology; reviewer (in 2013) for Journal Neuroscience Research, Free Radical Research, Pharmacological Reports, PLOS ONE, Journal of Cytology & Histology, Neurological Research; reviewer (from 2014) for Neurochemical Research, Neural Regeneration Research, Journal Neurological Disorders (4 times), Molecular Neurobiology, Journal Proteome Research (3 times), Neuroscience Letters (3 times), Recent Patents on CNS Drug Discovery (Bentham Science Eds), Neuroscience Research, British Medical Journal, Metabolic Brain Disease.

Research Interests: Biochemical studies (Functional Proteomics and Metabolomics) on Physiopathology and Pharmacology of the Central Nervous System in experimental conditions of hypoxia, ischaemia, hyperammoniaemia, ipoglycaemia on the cerebral energy metabolism and actions of drugs on the brain energy state; molecular mechanisms of ageing and drugs' interference; the study of Parkinson’s disease and drugs' actions in Dementia; clinical studies on Molecular Medicine and Human Genetics on patients affected by neurological diseases (Dementia) or Alzheimer’s disease.

Dr. Ronald Swatzyna received his Masters of Science and Doctorate of Philosophy from The University of Texas Arlington. Currently, he is the Director of Electro-Neurophysiology Research, Director of Neurotherapy at the Tarnow Center for Self-ManagementSM, and is an associate of Brain Science International. Dr. Swatzyna is a licensed clinical social worker supervisor, board certified in neurotherapy and biofeedback by the Biofeedback Certification International Alliance (BCIA). For 18 years, Dr. Swatzyna has analyzed and treated the most diagnostically challenging cases in both inpatient and outpatient settings. As a researcher, he has presented and/or published over 50 peer-reviewed papers on brain dysfunction, psychotropic medication and other related topics at national and international conferences and is a Special Editor for WebmedCentral plus and Clinical EEG and Neuroscience. In 2011, Dr. Swatzyna was inducted into Sigma Xi: The Scientific Research Society: Rice University/Texas Medical Center Chapter and in 2013, he accepted an appointment to the board of directors. Dr. Swatzyna is a veteran of both Vietnam and the first Gulf War, and his personal battle with a traumatic brain injury and posttraumatic stress disorder has motivated him to become a leading expert in brain dysfunction.

Research Interest: involve the utility of EEG and qEEG technology to assist with medication selection and titration.

Professor of Neurology, Senior Neurologist, Chairman of the Neurosciences Department, Faculty of Medicine, University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca, President of the Romanian Society of Neurology, President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN), member of the Academy of Medical Sciences, Romania, secretary of its Cluj Branch. He is also member of 13 scientific international societies (being member of the American Neurological Association (ANA) - Fellow of ANA (FANA) since 2012) and 7 national ones, being part of the executive board of most. Professor Dafin F. Muresanu is a specialist in Leadership and Management of Research and Health Care Systems (specialization in Management and Leadership, Arthur Anderson Institute, Illinois, USA, 1998 and several international courses and training stages in Neurology, research, management and leadership). Professor Dafin F. Muresanu is coordinator in international educational programs of European Master (i.e. European Master in Stroke Medicine, University of Krems), organizer and co-organizer of many educational projects: European and international schools and courses (International School of Neurology, European Stroke Organisation summer School, Danubian Neurological Society Teaching Courses, Seminars - Department of Neurosciences, European Teaching Courses on Neurorehabilitation) and scientific events: congresses, conferences, symposia (International Congresses of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN), International Association of Neurorestoratology (IANR) & Global College for Neuroprotection and Neuroregeneration (GCNN) Conferences, Vascular Dementia Congresses (VaD), World Congresses on Controversies in Neurology (CONy), Danube Society Neurology Congresses, World Academy for Multidisciplinary Neurotraumatolgy (AMN) Congresses, Congresses of European Society for Clinical Neuropharmacology, European Congresses of Neurorehabilitation). His activity includes involvement in many national and international clinical studies and research projects, over 300 scientific participations as “invited speaker” in national and international scientific events, a significant portfolio of scientific articles (120 papers indexed on Web of Science-ISI, H-index: 14) as well as contributions in monographs and books published by prestigious international publishing houses. Prof. Dr. Dafin F. Muresanu has been honoured with: the Academy of Romanian Scientists, “Carol Davila Award for Medical Sciences / 2011”, for the contribution to the Neurosurgery book “Tratat de Neurochirurgie” (vol.2), Editura Medicala, Bucuresti, 2011; the Faculty of Medicine, University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca “Octavian Fodor Award” for the best scientific activity of the year 2010 and the 2009 Romanian Academy “Gheorghe Marinescu Award” for advanced contributions in Neuroprotection and Neuroplasticity.

Neuroprotection, Neuroplasticity, Neuroregeneration

Partner at a personal injury law firm specializing in T.B.I. The National Trial Lawyers “Top 100 Trial Lawyers”. BS Magna Cum Laude 1990 and Juris Doctorate 1993. Vice-Chairman of B.O.D. Mothers Against Drunk Driving National. & B.O.D. Brain Injury Alliance. 20x year keynote at National Brain Injury Conferences. All honorariums donated to charities. Authored Spring Break: A True Story of Hope and Determination regarding a brain injured college student who received long-term inpatient, outpatient care and rehabilitation. Awarded: US Senate Official Proclamation, US Congressional Citation, U.S. House of Representatives Special Congressional Recognition, 20+ awards for legal and charitable accomplishments.

Traumatic Brain Injury

Starting as a young entrepreneur from the age of 18, and having launched several start-up businesses in the security industry, Kevin carried on his career as a sales and marketing executive, which has included over 35 years with major corporate divisions of ADT, BOSCH and Honeywell International. Author, inventor and patent holder, Kevin has traveled to Europe, Asia, India, Australia, the Middle East, Africa, South and Central America, and throughout North America to see how the world really lives. Kevin also has a personal story and connection to Dementia. His first wife, Ginny, together for 32 years, died from Dementia, and thus he leads the fight against all forms with thoughts, words and deeds. In 2016, Jameson was awarded a Doctorate of Public Service, Honoris Causa. His establishment of the Dementia Society of America, is a mission in the making.

Dementia

Dr. Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007.

Neurology, Neuroradiology, Epidemiology

Starting as a young entrepreneur from the age of 18, and having launched several start-up businesses in the security industry, Kevin carried on his career as a sales and marketing executive, which has included over 35 years with major corporate divisions of ADT, BOSCH and Honeywell International. Author, inventor and patent holder, Kevin has traveled to Europe, Asia, India, Australia, the Middle East, Africa, South and Central America, and throughout North America to see how the world really lives. Kevin also has a personal story and connection to Dementia. His first wife, Ginny, together for 32 years, died from Dementia, and thus he leads the fight against all forms with thoughts, words and deeds. In 2016, Jameson was awarded a Doctorate of Public Service, Honoris Causa. His establishment of the Dementia Society of America, is a mission in the making.

Dementia

Starting as a young entrepreneur from the age of 18, and having launched several start-up businesses in the security industry, Kevin carried on his career as a sales and marketing executive, which has included over 35 years with major corporate divisions of ADT, BOSCH and Honeywell International. Author, inventor and patent holder, Kevin has traveled to Europe, Asia, India, Australia, the Middle East, Africa, South and Central America, and throughout North America to see how the world really lives. Kevin also has a personal story and connection to Dementia. His first wife, Ginny, together for 32 years, died from Dementia, and thus he leads the fight against all forms with thoughts, words and deeds. In 2016, Jameson was awarded a Doctorate of Public Service, Honoris Causa. His establishment of the Dementia Society of America, is a mission in the making.

Dementia

Dr. Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007.

Neurology, Neuroradiology, Epidemiology

Mootaz Salman is a pharmacist and researcher PhD student at the Biomolecular Sciences Research Centre (BMRC) at Sheffield Hallam University, working with Prof. Nicola Woodroofe and Dr. Matthew Conner’s research group and a member of the multi-institute Aquaporin research collaboration. His research interest focus on the identification of new drug targets for brain oedema and epilepsy through his work on the special water channels called “Aquaporins”. Mootaz graduated with Outstanding Distinction in his MSc winning the Sheffield Hallam University prize for the most scientific contribution and ranked 1st in year. His PhD research requires the skilled use of numerous techniques ranging from standard biochemical and molecular biology to cutting edge micro-array and laser confocal microscopy. Mootaz is an international ambassador at Sheffield Hallam University, ambassador for British Society of Experimental Biology (SEB); and STEM ambassador since 2014. He has given four invited oral presentations and talks at major international conferences in Canada, Netherlands, Romania and Japan along with three talks at a national level. He is also an active member in a number of scientific societies nationally and internationally including USA, Canada and Japan. He has been selected to be an abstract reviewer at two major international conferences; Brain 2015 in Canada and also for the upcoming Brain 2017 in Berlin, along with being an abstract reviewer and a member of poster judgement panel during the North of England Postgraduate Conference (NEPG) which is the UK's largest annual postgraduate conference for medical biosciences. Mootaz has successfully participated in organising a number of national and international high profile conferences and also he has been selected to chair scientific sessions at two national events.

Molecular Pharmacology, Neurochemistry, Astrocytes and Cerebral Aquaporins